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VI 
ANTHONY AMBESI. Purification and Identification of the Cardiac Sarcolemmal 
Na+/Ca2+ Exchanger. (Under the direction of GEORGE E. LINDENMAYER, 
M.D., Ph.D. and ERVIN E. BAGWELL, Ph.D.) 
The cardiac sarcolemmal Na+/Ca2+ exchanger promotes the coupled 
movement of sodium and calcium across the cell membrane in a reversible, 
electrogenic manner. The goal of this study was to identify the protein(s) 
responsible for Na+/Ca2+ exchange across cardiac sarcolemma. 
Purification of the Na+/Ca2+ exchanger from canine ventricle was 
accomplished using the following sequence: 1) isolation of sarcolemma (SL); 2) 
alkaline extraction of membranes; 3) solubilization with CHAPS; 4) DEAE 
chromatography; 5) gel filtration HPLC; 6) addition of cholate, salt and 
phospholipids; 7) wheat germ agglutinin chromatography followed by 8) 
reconstitution into proteoliposomes by detergent dilution. Specific activity was 
increased from 5.2 (SL) to 3766 nmol/mg/sec with 100/0 recovery of activity and 
0.02% recovery of protein. SDS-PAGE of the purified Na+/Ca2+ exchanger 
preparation under reducing conditions revealed prominent proteins of 75, 120 and 
140 kDa. One major protein with a molecular mass of 140 kDa was detected under 
nonreducing conditions. Polyclonal antibodies against the reconstituted, purified 
Na+/Ca2+- exchanger preparation recognized the three proteins and 
immunoprecipitated 97.4%+1.3% (n=4) of the Na+/Ca 2+ exchange activity from 
detergent-solubilized sarcolemma. Subsequently, antibodies against the 75, 120 
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and 140 kDa proteins were antigen-purified and found to immunoprecipitate 92%, 
91 % and 83%, respectively, of the Na +/Ca2+ exchange activity from detergent-
solubilized sarcolemma. Furthermore, the antigen-purified antibodies 
cross-reacted with each of the other two proteins on immunoblots of sarcolemmal 
protein. Immunoblots with samples prepared from isolated canine ventricular 
myocytes revealed predominantly the 140 kDa protein and trace amounts of the 75 
kDa protein. The 120 kDa protein was not detected. 
The polyclonal antibodies were subsequently tested for the ability to affect 
Na +/Ca2t- exchange activity manifested by sarcolemmal vesicles. IgG from 
immune serum stimulated exchange activity 3.5-fold in a concentration .. 
dependent manner (EDso = 0.5 Jlg IgG/J.Lg sarcolemmal protein) while IgG from 
preimmune serum had little or no effect. Curiously, IgG from a rabbit 
immunized against total sarcolemmal protein stimulated activity nearly as much, 
but was unable to immunoprecipitate exchange activity. Stimulation appeared to 
be due to a small increase in V max and a larger decrease in the KO.5 for 
extra vesicular calcium. 
Molecular cloning of the canine cardiac Na+/Ca2+ exchanger has recently 
been reported (Nicoll et ala ,1990). RNA synthesized from the eDNA clone induced 
expression of Na +/Ca2+ exchange activity when injected into Xenopus oocytes. The 
eDNA codes for a protein of 970 amino acids (-108 kDa). Antibodies developed 
against a synthetic peptide based on the deduced amino acid sequence reacted with 
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sarcolemmal proteins of 70, 120 and 160 kDa. Antibodies generated against a 
partially purified canine cardiac Na+/Ca2+ exchanger preparation also recognized 
proteins of 70, 120 and 160 kDa (Philipson et al., 1988). These antibodies (provided 
by K. D. Philipson) recognized proteins of 75, 120 and 140 kDa on immunoblots of 
sarcolemmal protein and the purified Na+/Ca2+ exchanger preparation in this 
laboratory (Ambesi et al., 1991c). 
These data support the hypothesis that the 70-75, 120 and 140-160 kDa 
proteins are involved with Na+/Ca2+ exchange across cardiac sarcolemma and 
that the 70-75 and 120 kDa proteins are fragments of the 140-160 kDa protein 
formed during isolation of the sarcolemmal preparation. 
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The existence of a plasmalemmal Na+/Ca2+ exchange system was first 
hypothesized just over 20 years ago when Reuter and Seitz (1968) demonstrated 
that calcium effiux in atria was sensitive to extracellular concentrations of free 
sodium and calcium and that both cations interacted with a common site 
associated with the plasma membrane. Later, Baker et al. (1969) provided more 
direct evidence for the existence of a plasma membrane Na+/Ca2+ exchanger using 
internally perfused squid giant axons and further proposed that a Na +/Ca2f. 
exchange system could explain the positive inotropic effect observed with cardiac 
glycosides. Research on the cardiac Na +/Ca2t- exchanger has received much 
attention as a result of the known regulatory effects of Na+ and Ca2+ on cardiac 
excitation-contraction coupling, implicating Na+/Ca2+ exchange as a key 
modulator of myocardial contractility_ 
In light of the recent advances in both experimental design and techniques, 
the role of Na+/Ca2+ exchange in cardiac excitation-contraction coupling is slowly 
beginning to emerge with emphasis being placed upon myocardial relaxation 
(Ca2+ effiux) as its primary function. However, the Na +/Ca2+ exchanger can also 
operate in a Ca2+- influx mode suggesting a role in Ca2 +-mediated cardiac 
contraction. Thus, the physiological role of the Na+/Ca2+ exchanger in the 
regulation of intracellular Ca2t in cardiac tissue remains somewhat 
controversial. Uncertainty concerning the physiological role can be attributed to a 
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number of factors including: (1) the difficulty in obtaining purified preparations of 
the cardiac Na+/Ca2+ exchanger; (2) the lack of selective inhibitors of Na+/Ca2r 
exchange; and (3) the presence of multiple Na+ and Ca2+ flux pathways which 
greatly increases the complexity of cardiac excitation-contraction coupling (Figure 
1). 
While the original goal of this study was to identify the protein(s) 
responsible for Na+/Ca2+ exchange across cardiac sarcolemma (SL) and not 
necessarily to purify them, the results presented herein, and those reported in the 
literature subsequent to the initiation of this project, suggest that we have 
developed fractionation procedures which purify the cardiac Na +/Ca2+ exchanger 
to near-homogeneity. Purification of the protein(s) responsible for Na+/Ca24-
exchange and manipulation of cDNA clones encoding the active exchanger should 
ultimately permit a closer inspection of its biochemical properties and provide 
additional insight into its physiological role in cardiac excitation-contraction 
coupling. 
In this introductory chapter, several aspects of Na+/Ca2+ exchange will be 
presented and discussed including: (1) stoichiometry and thermodynamics, (2) 
kinetics, (3) regulation, (4) physiological role of Na+/Ca2+ exchange and (5) 
discussion of past and present attempts to purify the proteins responsible for 





Figure 1. Ion Transport Pathways in a Cardiac Myocyte which Playa Role in the 
Regulation of Intracellular Ca2+. Ca 2+ is transported either into or out 
of the cytosol in response to physiological signals (e.g., changes in ion 
gradients, depolarization, ligand binding). A, L-type Ca 2+--channel 
(voltage-gated); B, Na+,K+-ATPase; C, Na+/Ca2+ exchanger; D, 
sarcolemmal Ca2+--ATPase (calmodulin-sensitive); E, sarcoplasmic 
reticulum Ca2+-ATPase (calmodulin-insensitive); F, sarcoplasmic 
reticulum Ca2 + release channels (Ca2 +-dependent and receptor-
operated); G, mitochondrial Na+/Ca2+ exchanger; H, mitochondrial 
Ca2 + uniporter; MIT, mitochondrion; SL, sarcolemma; SR, 
sarcoplasmic reticulum; TT, transverse tubule. 
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STOICHIOMETRY AND THERMODYNAMICS OF Na+/Ca2+ EXCHANGE 
The stoichiometry of Na+/Ca2+ exchange dictates the potential 
physiological significance of Na +/Ca2+ exchange in regulating intracellular free 
calcium concentration. For example, a stoichiometry of 2 Na+:l Ca2+ implies an 
electroneutral exchange process which is independent of membrane potential and 
would be unable to reduce intracellular calcium to basal levels (Blaustein, 1974). 
Moreover, evidence supporting electrogenic exchange suggests that the 
stoichiometry is greater than 2 Na+:l Ca2+-. Studies designed to determine the 
stoichiometry ofNa +/Ca2f. exchange were carried out initially in intact squid giant 
axons and gave results consistent with 2-5 Na+ transported per Ca2+- (Baker et al., 
1969; Blaustein and Russel, 1975). Intracellular organelles, however, can 
accumulate or release calcium and lead to incorrect estimates. 
Subsequently, plasma membrane vesicles were used to measure 
isotopic fluxes of Na+ and Ca2+-. Pitts (1979) used simultaneous initial rate 
measurements of 22Na+ influx and 45Ca2+- efflux in cardiac sarcolemmal vesicles 
and demonstrated a stoichiometry of 3 Na+:1 Ca2+-. Wakabayashi and Goshima 
(1981a) reported similar results by measuring calcium flux in fetal mouse cardiac 
cells. Reeves and Hale (1984) generated potential differences across cardiac 
sarcolemmal vesicles to drive Na+/Ca2+ exchange while determining the Na+ 
gradient necessary to prevent net Ca2+ flux. Their results further supported a 
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stoichiometry of 3 Na+:l Caa... Through measurement of Na+/Ca2+ exchange 
currents in isolated guinea-pig ventricular cells, Kimura et ale (1987) determined 
a reversal potential consistent with a stoichiometry of 3 Na +:1 Caa... In addition to 
those cited above, there have been numerous reports supporting a stoichiometry of 
3 Na+:l Ca2+ (Bers et al., 1980; Caroni et al. ,1980; Philipson and Nishimoto, 1980; 
Reeves and Sutko, 1980; Reeves et al., 1980; Sheu and Fozzard, 1982; Allen et al., 
1983; Kimura et al., 1987). 
Besides squid axon, a stoichiometry of 3 Na+:l Caa.. has also been 
reported for Na+/Ca2+ exchange in certain noncardiac tissues including vascular 
smooth muscle (Ashida and Blaustein, 1987; Kahn et al., 1988) and barnacle 
muscle (Rasgado-Flores and Blaustein, 1987). In contrast, the Na+/Ca2+ 
exchanger localized to the outer segment plasma membrane of retinal rod cells 
exhibits a requirement for K+ and has a stoichiometry of 4 Na+:l Ca2t + 1 K+ 
(Lagnado and McNaughton, 1989). Recent evidence, however, suggests that the 
cardiac sarcolemmal N a+ /Ca2+ exchanger protein is structurally different 
(separate gene products with no homology) from that of retinal rod cells (Cook et 
al., 1991). 
The relationship between the concentration of intracellular free 
calcium and the other determinants of the exchange reaction at equilibrium can 
be expressed by the equation shown below based on a stoichiometry of 3 Na+:l Ca2+-
(Blaustein, 1974): 
7 
Where i and 0 refer to free cation concentrations in the intracellular and 
extracellular spaces, respectively; Em is the membrane potential; F is the Faraday 
constant; R is the gas constant; and T is the absolute temperature in degrees 
Kelvin. 
The above equation predicts [Ca2+-]i for Na+/Ca 2+ exchange at equilibrium. 
Given that the cell exists in a steady state under physiological conditions, the 
usefulness of the equation is limited to predicting the direction of net calcium flux 
via Na +/Ca2+ exchange. For example, if the [Ca2+-]i calculated from the equation 
were higher than the actual concentration, then the exchanger would tend to 
move net calcium into the cell in an attempt to reach equilibrium for the exchange 
reaction. Substituting appropriate values for [Ca2+ ]0' [Na+]i and [Na +]0 (1.5, 7.5 and 
144 mM, respectively; Philipson, 1990) at 37° and a membrane potential of .. 85 m V 
(phase 4 of the action potential), the [Ca2+ ]i calculated from the equation is - 0.009 
JlM (one order of magnitude lower than the 0.06 .. 0.3 J.1M typically observed; Sheu et 
al., 1984; Chapman, 1986). Thus, the equation predicts that the exchanger will 
move calcium in the direction of net calcium efflux in an attempt to reach 
equilibrium. Subsequent to the onset of an action potential and membrane 
depolarization (approximately 20 mY; phase 0 of the action potential), [Ca2t-]i 
initially remains near basal levels. Under equilibrium conditions for the 
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exchange reaction, the equation predicts an [Ca~ Ji (0.5 J.1M) which is 
approximately 2-8-fold greater than resting calcium (0.06-0.3 J,lM). Thus, Na+/Ca2+ 
exchange favors net calcium influx. Yet, depolarization activates voltage-
dependent Ca2t-channels in the plasma membrane which leads to Ca2+--induced 
Ca2+ release from internal stores and an increase in [Ca2+ h to - 0.6-10 J.LM (phase 2 
of the action potential). Under these conditions, the equation predicts that the 
exchanger will begin to reverse direction and move calcium out of the cell. 
Furthermore, one might predict that the driving force for calcium efflux via 
Na+/Ca2+ exchange would be greatest immediately following membrane 
repolarization (phase 3 of the action potential), given that [Ca2+]i is elevated and 
the cell is repolarized. 
From a thermodynamic standpoint, it appears that Na+/Ca2+ exchange in 
cardiac muscle alternates between Ca2+--efflux and Ca2+-influx modes depending 
upon the state of the cell. The relative contribution of each transport mode to 
calcium homeostasis, however, remains uncertain and will be addressed below 
under "Physiological Rolen. 
KINETICS 
The physiological role of Na+/Ca2+ exchange in cardiac excitation-
contraction coupling will depend upon how effectively the exchanger can compete 
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with other calcium transport pathways in the cardiac cell. This in turn will 
depend upon various kinetic parameters of Na+/Ca2f. exchange including the 
exchanger's affinity (KM) for internal and external Na+ and Ca2t- and how quickly 
(V max) it can transport Ca~ across the cell membrane. A great deal of data 
concerning the kinetics of Na+/Ca2+ exchange have been acquired from studies 
using cellular or tissue preparations and, in particular, sarcolemmal vesicles. 
Because of the technical difficulties associated with patch clamp studies on 
whole cell preparations, such as the presence of multiple cellular compartments 
and the need to block other Ca2+- transport pathways, determination of kinetic 
parameters is accompanied by much uncertainty. However, cellular preparations 
offer the advantage of being in a more physiological state. Conversely, membrane 
preparations offer a system in which quantitative data can easily be obtained; and 
in fact, much of the data reported in the literature has been obtained from isolated 
membrane preparations. However, kinetic data generated from vesicular 
preparations are not free of uncertainty. For example, isolation of membrane 
preparations may result in the loss of endogenous regulators or alteration of the 
proteins responsible for exchange activity. Furthermore, membrane preparations 
are typically comprised of both inside-out and right-side-out oriented vesicles. 
Nonetheless, the cardiac Na+/Ca2+ exchanger appears to be a relatively 
high capacity, high turnover transporter with a relatively low affinity for Ca2+ 
(Philipson, 1990). 
1 0 
Ca2+ Transport Site 
Typical values for the KO.5 for Ca2+- based on Na +j-dependent Ca2+ uptake 
into cardiac sarcolemmal vesicles range from 10 to 40 JlM (e.g., Table 1 in Reeves 
and Philipson, 1989). The use ofCa2+- chelators such as EGTA has been reported to 
lower the KO.5 for Ca2+- to -1 J.1M (Caroni et al., 1980; Caroni and Carafoli, 1983; 
Trosper and Philipson, 1984). Assessment of the exchanger's affinity for Ca~ in 
vesicular preparations, however, may be erroneous due to the presence of vesicles 
with mixed polarities. One might intuitively expect the exchanger to exhibit high 
affinity for Ca2+ on the intracellular surface and low affinity for Ca2+ on the 
extracellular surface. If this were so, and Na+/Ca2+ exchange were asymmetric, 
then ion flux measurements across sarcolemmal vesicles would display two 
compartment kinetics and curvature would be observed in Eadie-Hofstee plots. 
This has not been reported. Philipson and Nishimoto (1982a) took advantage of the 
presence of the N a +,K +-ATPase to load inside-out cardiac sarcolemmal vesicles 
with Na+. Na+j-dependent Ca2+ uptake was then measured and compared with 
that measured in the total vesicular population. The affinity for calcium on the 
intracellular surface (33 JlM) was reported to be identical to that on the 
extracellular surface (see also Philipson, 1985). 
In more intact cellular preparations using isolated cardiac myocytes, the 
Ko.5 reported for extracellular Ca2+ is typically much higher ranging from 150 JlM 
to 1.4 mM suggesting that there is indeed some asymmetry with respect to the 
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exchanger's affinity for Ca2t- on the intracellular and extracellular surfaces 
(Wakabayashi and Goshima, 1981b; Kimura et al., 1987; Vemuri et al., 1989). 
Studies of exchange activity in internally perfused squid axons support this notion 
in that the apparent KO.5 for Ca2+ is different for external and internal Ca2f. 
transport sites (3 mM and 10 JlM, respectively; Baker and McNaughton, 1978). 
Na+ Transport Site 
The data concerning Na+ binding to the Na+/Ca2+ exchanger appears less 
controversial with respect to binding asymmetry (Philipson, 1985). Na+·dependent 
Ca2+ transport exhibits a sigmoidal dependency on Na+ concentration with a Hill 
coefficient of 2·3 which is consistent with the proposed 3 Na+ : 1 Ca2f. stoichiometry 
(Philipson and Nishimoto, 1981; Wakabayashi and Goshima, 1981a; Kadoma et al., 
1982; Reeves and Sutko, 1983; Caroni and Carafoli, 1983; Philipson, 1985; de la 
Pena and Reeves, 1987). The KO.5 for Na + typically falls within the range of 20 to 30 
mM and has been reported from studies using both cardiac sarcolemmal vesicles 
and cardiac cells (Wakabayashi and Goshima, 1981a; Kimura and Miura, 1988). 
The observation that Na+ and Ca2+ compete for ion binding sites on the 
exchanger (competitive inhibition; Ki for Na + is -16 mM with a Hill coefficient of 2 
at high [Na+]) has led to the development of a model in which two binding sites 
(site A and site B) on each side of the membrane were proposed (Reeves and Sutko, 
1983). At the A-site (Ca2f. binding site), either one Na+ or two Na+ can bind where 
1 2 
only one Na+ is necessary to effectively prevent Ca2+ binding. Binding of two Na + to 
the A-site results in a conformational change which allows a third Na + to bind to 
the B-site. According to this model, occupation of both the A-site and B-site by 
three Na + and the A-site by Ca2+ on the trans membrane side is required for 
Na+/Ca2+ exchange. 
Alternate Transport Modes 
Interestingly, the Na+/Ca2+ exchanger has also been shown to undergo Ca2+-
Ca2+ exchange (Bartschat and Lindenmayer, 1980; Philipson and Nishimoto, 1981; 
Slaughter et al., 1983; Philipson et al., 1988) and Na+-Na+ exchange (DiPolo and 
Beauge, 1987). In addition, alkali metal ions have been shown to stimulate Ca2+--
Ca2+ exchange (K-Rb-Li>Cs»choline) by increasing the V max (Coutinho et al., 
1983; Philipson and Nishimoto, 1981; Slaughter et al., 1983). 
Capacity and Turnover Rate 
As previously mentioned, the cardiac Na+/Ca2+ exchanger is a relatively 
high capacity Ca2f. transporter. V max rates of 5-30 nmol Ca2t- transported/mg/sec 
are consistently reported for cardiac sarcolemmal vesicles which translates to 
Ca2+ flux rates of -10-30 pmo]Jcm2/sec in the intact cardiac cell (Chapman, 1983). 
Flux rates reported in membrane vesicles prepared from brain (Schellenberg and 
Swanson, 1981; Gill et ale , 1984), pituitary (Kaczorowski et al., 1984), and vascular 
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smooth muscle (Morel and Godfraind, 1984), are typically much lower. More 
recent results using isolated synaptosomal preparations from rat brain, however, 
suggest that the brain Na+/Ca2+ exchanger may be as active as that of cardiac 
tissue (Fontana and Blaustein, 1991). 
The turnover rate has been estimated to be about 1000 Ca2f. sec- l for the 
cardiac exchanger reconstituted into proteoliposome preparations by Cheon and 
Reeves (1988) using indirect methods. Niggli and Lederer (1991) estimated the 
turnover rate to have an upper limit of about 2500 Ca2t- sec-l based on Na+/Ca2+ 
exchange currents in isolated guinea-pig myocytes using patch clamp techniques. 
Estimates of the turnover rate based on purified cardiac Na+/Ca2+ exchanger 
preparations range from -150 Ca2t- sec-l (Philipson et al., 1988) to 527 Ca 2+ sec-1 at 
V max (see chapter III). Conversely, the turnover rate estimated from activities of 
purified rod outer segment Na +/Ca2+ exchange preparations is somewhat lower at 
30-50 Ca2+ sec·l (Cook and Kaupp, 1988; Nicoll and Applebury, 1989). 
REGULATION 
The modulation of Na+/Ca2+ exchange activity in cardiac and noncardiac 
membrane preparations and in intact cells by a number of factors has been 
reported. The physiological significance of each of these factors has not yet been 
established. The mechanisms thought to modulate Na +/Ca2+ exchange activity 
are: 
(1) Phosphorylation of the exchanger; 
(2) regulation by intracellular ea2+-; 
(3) modulation by pH; 
(4) activation by proteolysis; 
(5) modulation by constituents of the membrane environment. 
Phosphorylation of the Exchanger 
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Stimulation of Na +/Ca2+ exchange activity with ATP was initially reported 
in internally dialyzed squid axons (Blaustein, 1977; DiPolo and Beauge, 1983; 
DiPolo, 1985; DiPolo and Beauge,1986; DiPolo and Beauge, 1987; DiPolo and 
Beauge, 1988). Activation of exchange activity exhibited a requirement for internal 
Mg2+ (DiPolo and Beauge, 1984) and was found to be selective for ATP (ADP, GTP, 
UTP, ITP, AMP, cAMP, acetylphosphate, and phosphoarginine were ineffective; 
DiPolo, 1976). While hydrolyzable ATP analogues <a,B-methylene ATP and 2-deoxy-
ATP) also stimulated exchange activity, the non-hydrolyzable ATP analogue B;y-
methylene ATP was ineffective (DiPolo, 1977). Subsequently, DiPolo and Beauge 
(1987) demonstrated activation of the exchanger with [y-S]ATP which is a substrate 
for protein kinases but not for ATPases. These results are consistent with the 
interpretation that the ATP effect is the result of phosphorylation mediated by a 
1 5 
calcium-dependent protein kinase. The mechanism by which ATP stimulates 
exchange activity in squid axon appears to he by increasing the exchanger's 
affinity for Ca2t on the intracellular surface at the Ca2+ regulatory site (discussed 
below) from -10-15 J.1M to -1-4 J.1M (DiPolo and Beauge, 1988). 
The regulation of Na+/Ca2+ exchange activity by ATP has also been reported 
in barnacle muscle (Blaustein, 1977; DiPolo and Beauge, 1983) and cultured aortic 
smooth muscle cells (Vigne et al., 1988). Evidence for ATP stimulation of Na+/Ca2+ 
exchange in cardiac tissue is less certain. Carafoli and associates reported 
activation of exchange activity with ATP in sarcolemmal vesicles using a Ca2+--
calmodulin-dependent protein kinase and phosphatase (Caroni and Carafoli, 1983; 
Reinlab et al., 1987). However, others have been unable to reproduce their results 
(Philipson, 1990). 
Hilgemann (1991) used giant excised membrane patches from cardiac 
myocytes to demonstrate a stimulatory effect of Mg2+-ATP (KM (ATP) -1.5 mM) on 
exchange activity. While the effect could be blocked with pentalysine (binds to 
• 
phosphatidylserine head groups), protein kinase and phosphatase inhibitors had 
no effect. Hilgemann (1991) postulated that the mechanism by which ATP exerts 
its modulatory effect in cardiac cells was indirect, via an aminophospholipid 
translocase which establishes membrane asymmetry (phosphatidylserine and 
anionic membrane components stimulate exchange activity, discussed below). 
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Regulation by Intracellular Ca2+ 
An interesting finding is the absolute requirement of the exchanger for 
internal Ca2+ in order to mediate Na+i-dependent Ca2+ influx. Although first 
reported in squid axon (Baker and McNaughton, 1976; DiPolo, 1979; DiPolo and 
Beauge, 1986; DiPolo and Beauge, 1987), internal Ca 2+ regulatory sites have also 
been reported in cardiac cells (Kimura et al., 1986; Kimura and Miura, 1988; Noda 
et al., 1988), cardiac sarcolemmal preparations (Reeves and Poronnik, 1987) and 
barnacle muscle (Rasgado-Flores and Blaustein, 1987). ATP has been reported to 
increase the affinity for Ca2+ at the Ca2t- regulatory site (Ko.5 decreased from 10-15 
JlM to 1-4 J,LM; DiPolo and Beauge, 1988). Calcium binding at the regulatory site 
has been shown to increase the affinity for Na+ and the maximal rate of exchange 
(DiPolo and Beauge, 1988). In internally perfused ventricular myocytes, the KO.5 
for Ca2+- at the regulatory site has been reported to be -20-50 nM (Kimura and 
Miura, 1988; Noda et al., 1988) which may suggest differences between the cardiac 
and squid axon exchangers. 
Reeves and Poronnik (1987) looked at the modulation of Na +/Ca2+ exchange 
activity in bovine cardiac sarcolemmal vesicles by intravesicular Ca2+. While 
Na+/Ca2+ exchange activity in sarcolemmal vesicles exhibited no absolute 
requirement for intravesicular Ca2+-, internal Ca2+ was reported to increase the 
affinity of the exchanger for extravesicular Ca2+. However, the effect could not be 
saturated even at values of 1 mM intravesicular Ca2+- and was, therefore, 
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suggested to be nonspecific having no bearing on theCa2+- regulatory site (Reeves 
and Poronnik, 1987; de la Pena and Reeves, 1987). A hypothesis proposed by 
Hilgemann (1988) suggests that the Ca2+- regulatory site may serve as a protective 
mechanism for the cell by preventing the exchanger from lowering intracellular 
Ca2+ too low. Thus, as intracellular Ca2+- levels drop below -0.1 J.1.M, Ca2t- would 
dissociate from the Ca2+ regulatory site and Ca2+- efllux via the exchanger would 
cease. 
Modulation by pH 
Na +/Ca2+- exchange activity in heart displays sigmoidal dependency on pH 
increasing from pH 6 to pH 9 (Wakabayashi and Goshima, 1981b; Philipson et al., 
1982; Slaughter et al., 1983). The effect of pH on Na+/Ca2+ exchange activity has 
also been reported in squid axon (DiPolo and Beauge, 1982). At low pH, protons 
compete with Ca2+- for Ca2f. binding sites on the exchanger, thereby inhibiting 
Na+/Ca2t exchange activity. This may have significance in certain pathological 
conditions in which intracellular pH is altered (e.g. pHi is lowered in ischemic 
myocardium) . 
. Activation by Proteolysis 
While activation of Na+/Ca2+ exchange activity in cardiac sarcolemmal 
vesicles by limited protease treatment has been reported (Philipson and 
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Nishimoto, 1982), assigning a physiological relevance to proteolysis in the in vivo 
situation is more difficult. One might conceive that under certain physiological 
states or pathological conditions, selective proteolysis of the N a +/Ca2+ exchanger 
could occur and increase Na+/Ca2+ exchange activity_ Whether activation of the 
exchanger occurs through proteolysis of the exchanger itself, inhibitory proteins 
or both is unclear. Nonetheless, proteolysis of the cardiac Na+/Ca2+ exchanger 
clearly occurs during membrane isolation and purification of the exchanger 
(Philipson et al., 1988; see chapter III) and has delayed conclusive identification of 
the proteins responsible for Na+/Ca2t- exchange across cardiac sarcolemma. 
Modulation by Constituents of the Membrane Environment 
The effects of the lipid environment in cardiac sarcolemmal and 
reconstituted preparations on Na+/Ca2+ exchange activity has been extensively 
studied. In general, exchange activity is enhanced in the presence of certain 
anionic membrane constituents and diminished in the presence of certain cationic 
membrane constituents. Treatment of sarcolemmal vesicles with phospholipase 
C (preferentially hydrolyzes neutral phospholipids resulting in a membrane 
relatively enriched with negatively charged phospholipids; Philipson et al., 1983) 
and phospholipase D (converts neutral phospholipids to phosphatidic acid; 
Philipson and Nishimoto, 1984) were reported to enhance Na+/Ca2+ exchange 
activity 2- and 4-fold, respectively. 
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In reconstitution experiments where the membrane components are easily 
manipulated, Vemuri and Philipson (1988) showed that cardiolipin and 
phosphatidylserine were required for high exchange rates. Small anionic 
amphiphiles such as sodium dodecylsulfate (SDS) and fatty acids added to 
sarcolemmal vesicles were also shown to enhance Na+/Ca2+ exchange activity 
(Philipson, 1984; Philipson and Ward, 1985; Philipson and Ward, 1987; Vemuri 
and Philipson, 1989). 
PHYSIOLOGICAL ROLE 
The physiological role of Na+/Ca2+ exchange in cardiac excitation-
contraction coupling has been a subject of much debate and controversy. In light 
of the recent advances in patch-clamp techniques, the development of Ca2 + 
sensitive dyes and pharmacological and biochemical approaches, the role of 
Na+/Ca2f. exchange as a major Ca2 + efflux system involved in myocardial 
relaxation is beginning to unfold. 
Following the onset of an action potential, Ca2t- enters the cytosol from both 
extracellular (through L-type Ca2+ channels) and intracellular stores (through 
Ca2+ release channels in the sarcoplasmic reticulum). Subsequently, an 
equivalent amount of Ca2+- must be removed from the cytosol prior to the beginning 
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of the next excitation-contraction cycle in order to maintain Ca2f. homeostasis. 
Ca2+ is sequestered into sarcoplasmic reticular stores via the SR ATP-dependent 
Ca2+ pump. In contrast, there are two systems in the plasma membrane of the 
cardiac cell which return calcium to the extracellular space: (1) the SL ATP-
dependent Ca2f. pump and (2) the Na+/Ca2+ exchanger. The question as to the 
relative contribution of each of these systems to Ca2+ removal and cardiac 
relaxation has been addressed in a number of studies (Murphy et ale , 1986; Barry 
et al., 1986; Bridge et al., 1988; Bers and Bridge, 1989; Bridge et al., 1990; Cannel, 
1991; Bers, 1991). 
Caffeine added to a myocyte or muscle superfusate (inhibits SR Ca2+-· 
ATPase) decreased the rate of relaxation by -70% while a Na+-free and Ca2f.-free 
superfusate (inhibits Na+o-dependent Ca2+effiux) slowed relaxation by -30% (Bers, 
1991). Furthermore, relaxation was almost completely abolished when Na+/Ca2+ 
exchange and the SR Ca2+-ATPase were simultaneously blocked. Cannel (1991) 
obtained similar results from patch-clamp studies using voltage-clamped, single 
cardiac myocytes while measuring intracellular Ca2+-. In these studies, Na+/Ca2+ 
exchange was reported to contribute little to the rise in intracellular Ca2+- leading 
to contraction, but was responsible for -15% of the Ca2+- effiux during relaxation. 
Bridge et al., (1990) treated guinea pig ventricular myocytes with caffeine in the 
absence of extracellular sodium and induced contraction by depolarization (voltage 
clamp from -40 mV to 0 mY). Upon repolarization, however, the cells were unable 
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to relax due to inhibition of the SR Ca2+-ATPase and the Na+/Ca2+- exchanger. 
Addition of extracellular Na + caused immediate relaxation and was attributed to 
Na+o-dependent calcium efflux via the Na+/Ca2+ exchanger. These data suggest 
that Na+/Ca2f. exchange accounts for -80-100% of the Ca2+ effiux from cardiac cells 
and -15-30% of the total Ca2+- removed from the cytosoL Moreover, the contribution 
of the SL Ca2 +-ATPase to Ca2+- efflux and cardiac relaxation appears to he 
negligible. 
Evidence that Na+/Ca2+ exchange may contribute to Ca2f. influx subsequent 
to the onset of an action potential (see "Stoichiometry and Thermodynamics of 
Na+/Ca2f.. exchange") leads one to suspect that Na+/Ca2+ exchange may also playa 
role in cardiac contraction. Leblanc and Hume (1990) treated guinea pig 
ventricular myocytes with 5 JlM nisoldipine (L-Type Ca2f.-channel blocker) and 
demonstrated an elevation in [Ca2+]i upon membrane depolarization which was 
dependent on sodium influx through tetrodotoxin-sensitive Na+-channels. In 
addition, the rise in intracellular calcium was dependent on [Ca2+]o. These data 
suggest that calcium entry via Na+/Ca2+ exchange may contribute to Ca2+-induced 
Ca2+ release from intracellular stores and myocardial contraction. Lederer et al. 
(1990) point out that the rise in [Na+]i during membrane depolarization would be 
inadequate to elevate [Ca2+- li sufficiently via Na+/Ca2+ exchange to induce calcium 
release from the SR. Restricting Na+ diffusion to just below the membrane 
surface, however, may result in sufficiently high [Na+]i in the vicinity of the 
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exchanger to allow enough Ca2+- to enter the cell through Na+/Ca2+ exchange and, 
thereby, to induce Ca2+ release from the SR (Lederer et al, 1990). 
It seems clear that one role of Na+/Ca2+- exchange in cardiac relaxation is to 
remove from the cytosol an amount of Ca2f. equal to that which enters through 
voltage-dependent Ca 2+ channels in the plasma membrane during the plateau 
phase of the action potential. The role of Na+/Ca2+ exchange in Ca2t-induced Ca2+-
release remains less certain. 
PURIFICATION 
In recent years, there have been a number of attempts to identify and isolate 
the proteins responsible for Na+/Ca2+ exchange across cardiac sarcolemma (Hale 
et al., 1984; Soldati et al., 1985; Philipson et al., 1988; Durkin et al., 1990; Ambesi et 
al., 1990; Durkin et al., 1991; Ambesi et ale ,1991). Attempts at identification were 
based on a correlation between a specific protein band upon SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE) and increased transport activity. While 
meaningful increases in specific activity were obtained (see below), none of the 
earlier attempts to purify the exchanger were conclusive in identifying the 
protein(s) responsible for Na +/Ca2+- exchange. Some of the difficulty faced in 
identifying and isolating the Na +/Ca2+ exchanger can be attributed to three 
considerations: (1) The Na +/Ca2+- exchanger is a high-turnover, low abundance 
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protein (Philipson et al., 1988; Ambesi et al., 1990; Ambesi et ale 1991a; see chapter 
III; Durkin et al., 1991); (2) there are no specific, high affinity ligands which can 
be used to follow the exchanger during fractionation or coupled to affinity supports 
for purification (Kaczorowski et al., 1989); and (3) subsequent to fractionation, all 
samples must be reconstituted into sealed proteoliposomes for assay of exchange 
activity (i.e., based on Na +-dependent Ca2+ flux). To further complicate matters, 
limited proteolysis (Philipson and Nishimoto, 1982b), alkaline pH (Wakabayashi 
and Goshima, 1981b; Philipson et al., 1982; Slaughter et al., 1983; Vemuri and 
Philipson, 1988), phospholipase treatment (Philipson et al., 1983; Philipson and 
Nishimoto, 1984) and incorporation of certain components into reconstituted 
vesicles (Philipson, 1984; Philipson and Ward, 1985; Philipson and Ward, 1987; 
Vemuri and Philipson, 1988; Vemuri and Philipson, 1989) can have dramatic 
effects on activity (see "Regulationft above). 
In order to assess purification of exchange activity following fractionation, 
one must take into account the loss of exchanger units during fractionation and 
the incorporation of exchanger units from leaky vesicles in the sarcolemmal 
preparation (exchange activity not detected) into sealed proteoliposomes (exchange 
activity detected). Thus, purification is typically calculated relative to activities of 
control proteoliposomes (solubilized and reconstituted sarcolemmal protein) 
instead of the sarcolemma-enriched preparation (starting source for purification). 
However, several considerations should be noted: (1) the sarcolemmal preparation 
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used in this laboratory as the starting source for purification of the Na+/Ca2+ 
exchanger is substantially enriched with sarcolemmal markers (i.e., 
approximately 66-fold over homogenate; VanAlstyne et al., in preparation); and 
(2) I am convinced that some purification occurs by solubilization and 
reconstitution per se, although, the amount cannot be specified because the extent 
of loss of exchanger units and degree of activation are currently unknown (see 
chapter II). 
Hale et al. (1984) solubilized bovine cardiac sarcolemmal vesicles with 
cholate in the presence of soybean phospholipids (asolectin), treated the 
supernatant with Pronase, and increased specific activity 3D-fold in reconstituted 
proteoliposomes when compared to native sarcolemmal vesicles (native 
sarcolemmal vesicles = 4.1 nmols/mg/sec; control reconstituted vesicles = 19.7 
nmols/mg/sec; Pronase treated, reconstituted vesicles = 128 nmol/mg/sec). 
Enrichment correlated with an 82 kDa band on SDS-PAGE. However, later reports 
suggested that the 82 kDa protein could be separated from Na+/Ca2+ exchange 
activity (Philipson et al., 1988). 
Soldati et al. (1985) solubilized the Na+/Ca2+ exchanger from a bovine 
cardiac sarcolemma-enriched preparation with Triton X-lOO in the presence of 
asolectin, fractionated activity by rate zonal centrifugation, and enriched Na+/Ca2+-
exchange activity 128-fold over native sarcolemma (sarcolemmal preparation = 7.1 
nmols/mg/sec; reconstituted vesicles = 94.4 nmols/mg/sec; fractionated activity = 
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908 nmols/mg/sec). Activity appeared to correlate with a 33 kDa band on 
SDS-PAGE. However, a large number of protein bands could be detected in their 
most enriched preparation. 
Prior to solubilization with cholatelasolectin and reconstitution by detergent 
dilution, Philipson et al. (1987) treated canine cardiac sarcolemmal vesicles with 
an alkaline medium (10 mM cyclohexylaminopropane sulfonic acid (CAPS)-
NaOH, pH 12; suggested to remove loosely bound peripheral proteins; Steck and 
Yu, 1983). Specific activity in reconstituted, alkaline-extracted sarcolemmal 
vesicles was enriched 2-fold over that of control reconstituted vesicles with little or 
no loss of exchange activity (reconstituted control vesicles = 31 nmols/mg/sec; 
reconstituted alkaline-extracted vesicles = 64 nmols/mg/sec). Using alkaline 
extraction, DEAE-Sepharose chromatography, and immobilized wheat germ 
agglutinin chromatography in series, Philipson et ale (1988) were able to enrich 
Na+/Ca24- exchange activity 27-fold over control reconstituted vesicles (sarcolemma 
= 5 nmols/mglsec; reconstituted vesicles = 24 nmols/mglsec; fractionated activity = 
654 nmols/mg/sec). Activity appeared to correlate with 70 and 120 kDa bands on 
SDS-PAGE under reducing conditions and 160 kDa under nonreducing conditions. 
Curiously, prolonged exposure to chymotrypsin resulted in the disappearance of 
the 70 and 120 kDa bands with little or no loss of activity. 
Polyclonal antibodies directed against the- enriched fraction 
immunoprecipitated 96% of the Na+/Ca2+ exchange activity from detergent-
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solubilized sarcolemma (Philipson et al., 1988). Later, Vemuri et al. (1990) 
developed monoclonal antibodies against their partially purified exchanger 
preparation. Antibodies from three independent clones were shown to 
immunoprecipitate 50-75% of the exchanger. Additional studies confirmed that 
proteins precipitated by the monoclonal antibodies were the same as those 
recognized by the polyclonal antibodies previously developed (Philipson et al., 
1988). The polyclonal antibodies generated against the partially purified 
exchanger preparation (Philipson et aI., 1988) were used to screen an amplified 
Agtl1 canine heart cDNA expression library and a partial clone (lacked the 5' 
coding region) was isolated (Nicoll et al., 1990). DNA probes developed from the 
clone were subsequently used to identify a cDNA clone from a canine heart 
oligo(dT)-primed cDNA library which had a 5' extension of 80 base pairs. RNA 
synthesized from this clone and injected into Xenopus laevis oocytes induced 
expression of Na+j-dependent Ca2t- uptake and provided strong evidence that the 
clone coded for the cardiac Na +/Ca2+ exchanger (Nicoll et al., 1990). 
OBJECTIVE AND SPECIFIC AIMS 
Objective 
The objective of this project was to identify the protein(s) responsible for 
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Na +/Ca2t- exchange across cardiac sarcolemma. 
Specific Aims 
The specific aims of the project were as follows: 
(1) To develop an improved solubilization and reconstitution procedure 
using zwitterionic and non-ionic detergents. 
(2) To develop a means to enrich the protein(s) responsible for Na+/Ca2+ 
exchange through ion-exchange chromatography. 
(3) To develop a means to enrich the protein(s) responsible for Na+/Ca2+ 
exchange through gel filtration chromatography. 
(4) To enrich further the protein(s) responsible for Na+/Ca2+ exchange by 
combining ion-exchange and gel filtration chromatography in series. 
(5) To test alternative hypotheses about the protein(s) responsible for 
Na +/Ca2+- exchange. 
Chapter II addresses Specific Aim 1, solubilization and reconstitution of 
the cardiac Na+/Ca2t- exchanger, and has been accepted by Analytical 
Biochemistry for publication (Ambesi et al., 1991e). 
Chapters III and IV address Specific Aims 2-5, purification and 
iden tifica tion of the cardiac sarcolemmal N a +/Ca2+ exchanger, and have been 
submitted to the Journal of Biological Chemistry for publication (Ambesi et al., 
1991b and Ambesi et al., 1991c, respectively). In addition, abstracts presented at 
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meetings of the Biophysical Society also cover Specific Aims 2-5 (Ambesi et ale , 
1990; Ambesi et al., 1991a). 
Chapter V includes data characterizing the effects of polyclonal antibodies 
on Na+/Ca2+ exchange activity. These results were presented at the New York 
Academy of Sciences "Second International Conference on Sodium/Calcium 
Exchange" and are in press for the proceedings of the conference (Ambesi et al., 
1991d). 
Chapter VI is a general discussion of the data presented here and in the 
literature concerning the identification of the protein{s) responsible for Na+/Ca2f. 
exchange across cardiac sarcolemma. 
CHAPTER II 
Sequential Use of Detergents for Solubilization and Reconstitution 
of a Membrane Ion Transporter 
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INTRODUCTION 
The purification of integral membrane proteins almost invariably requires 
solubilization of the protein with detergent followed by the application of one or 
more column chromatography procedures (Renswoude and Kempf, 1984). After 
purification, the protein must often be reconstituted into a lipid bilayer 
environment to assess function. One means to rapidly effect reconstitution in the 
presence of certain detergents is to dilute the mixed micellar system to reduce the 
level of the detergent to the point that proteoliposomes are formed (Racker et at., 
1979; Koepsell, 1986). In this regard, the anionic detergent cholate has been 
successfully employed for the solubilization and reconstitution of a number of 
integral membrane proteins (Racker et al., 1979; Racker, 1979; Koepsell, 1986). 
However, the use of cholate during purification has disadvantages (e.g., precludes 
ion exchange chromatography, see Renswoude and Kempf, 1984; Hjelmeland and 
Chrambach, 1984; may interfere with certain lectin affinity separations, see Lotan 
et at., 1977; Renswoude and Kempf, 1984). Thus, purification may be benefitted by 
solubilization with another detergent, fractionation in the presence of that 
detergent, followed by the addition of cholate and lipids for the reconstitution step_ 
Miyamoto and Racker (1980) first reported solubilization and reconstitution 
of the Na+/Ca2+ exchanger by use of cholate in the presence of soybean 
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phospholipids and high ionic strength. This paper reports modifications of the 
Miyamoto and Racker procedure (1980). The modifications allow an improved 
recovery of total and specific Na +/Ca2+ exchange activity upon reconstitution. In 
addition, the combination of solubilization with other detergents followed by 
reconstitution via the cholate dilution technique was examined. This sequence 
was found to be useful for several detergent combinations and could have utility for 
other integral membrane proteins. 
MATERIALS AND METHODS 
Materials 
3-[ (3-cholamidopropy l)-dimethy lammonio ]-I-propane sulfonate (CHAPS), 
n-octyl-B-D-glucoside, and Triton X-I00 were obtained from Pierce Chemical Co.; 
decyl-13-D-maltoside was from Calbiochem; cholic acid was from Serva; and 45Ca 
was from New England Nuclear. Asolectin (L-a-phosphatidylcholine, Type II-S) 
was obtained from Sigma Chemical Co., and was treated as previously described 
(Hale et al., 1984). All other chemicals were of reagent grade. 
Sarcolemma Enriched Preparations 
Cardiac ventricular tissue was removed from anesthetized dogs and 
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minced as previously described (VanAlstyne et al., 1980; Frankis and 
Lindenmayer, 1984). The following steps were carried out at a-5°C, pH values are 
for 5°C, and centrifugal forces are given as max RCF (relative centrifugal force). 
The mince was suspended in 5 volumes of 15 mM NaHCO g, 0.25 M sucrose, pH 7.0 
and subjected to one pass of a motor-driven Teflon pestle in a Potter-Elvehjem 
vessel (clearance approx. 0.318 mm). After centrifugation (1600 x g; 10 min), the 
pellet was rehomogenized and pelleted as described above. The pellet was then 
resuspended in 5 volumes of 10 mM Tris-CI, pH 7.2 by four motor-driven passes of 
a pestle (clearance approx. 0.254 mm). Mter centrifugation as above, the 
supernatant was collected. This step was repeated three times. The four 
supernatants were centrifuged (39,000 x g; 20 min), the pellets were separately 
resuspended in 0.25 volumes of 10 mM Tris-CI, pH 7.0, and each layered over 15 rol 
of 0.771 M sucrose, 10 mM Tris-CI, pH 7.4 in Beckman Type 30 rotor tubes. Mter 
centrifugation (73,000 x g; 30 min), the layer at the interface between the buffer and 
sucrose was harvested, diluted with 15-20 ml 10 mM Tris-CI, pH 7.4, and 
centrifuged (73,000 x g; 20 min). The pellets were washed once in the same buffer, 
resuspended at 2-4 mg/ml, frozen in liquid nitrogen, and stored at -70°C. 
Solubilization and Reconstitution of the Na+/Ca2+ Exchanger 
Membrane vesicles (1.5 mg/ml) were exposed to 160 mM NaCl, 10 mM 4-
morpholinepropanesulfonic acid (Mops)-Tris, pH 7.4 (Buffer I), for 12-18 hours on 
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ice (Na+-Ioading). Solubilization with cholate was carried out by a twofold dilution 
of the vesicle suspension with a solution containing cholate, asolectin, NaCI 
(concentrations specified under "Results and Discussion"), 10 mM Mops-Tris, pH 
7.4. Insoluble material was removed by centrifugation (180,000 x g; 30 min). 
Proteoliposomes were formed by dilution with Buffer I, collected by centrifugation 
(230,000 x g; 60 min), and washed once by resuspension and centrifugation. 
Proteoliposomes were resuspended in 100-300 J.1.1 of Buffer I and assayed for 
Na +/Ca2+ exchange activity and protein. 
Solubilization with detergents other than cholate was carried out by a 
twofold dilution of the Na+-Ioaded sarcolemmal vesicles with the detergent 
dissolved in Buffer I. Exposure to detergent was carried out on ice for 30 min with 
frequent vortexing. Subsequently, insoluble material was removed by 
centrifugation (180,000 x g; 30 min). Reconstitution by cholate dilution was 
achieved by diluting the solubilized fraction with an equal volume of 2% cholate, 
800 mM NaCI, 10 mM Mops-Tris, pH 7.4, 50 mg/ml asolectin which had been 
sonicated to a uniform suspension with a bath sonifier (Model W185F, Heat 
Systems-Ultrasonics, Inc.) and cleared of insoluble material by centrifugation 
(180,000 x g; 30 min). After incubation on ice for 5 min, proteoliposomes were 
formed by a threefold dilution with Buffer I, collected by centrifugation, and 
washed once as described above. 
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Assay for Na+/Ca2+ Exchanger 
Na+/Ca2+- exchange assays were carried out at 37°C for one sec according to 
the procedure of Reeves and Sutko (1983) using 40 J.1M 45Ca/CaC12 and 0.5 J.1M 
valinomycin and a stopping solution of 160 mM KCI, 1 mM EGTA, 10 mM 
Mops-Tris, pH 7.4. 
Miscellaneous 
Protein was determined by the method of Lowry et ale (1951) for 
sarcolemmal preparations. Protein of proteoliposome preparations was 
determined by modifications of the Schaffner and Weissmann procedure (1973) as 
described by Kaplan and Pedersen (1985). Bovine serum albumin (BSA) was used 
as a standard for all protein assays. The amount of insoluble material in the 
cholate/phospholipid suspension (prior to removal by centrifugation) was 
estimated by 90 0 light scatter at 550 nm using an Aminco Bowman 
s pectrophotofl uorom eter. 
RESULTS AND DISCUSSION 
Miyamoto and Racker (1980) reported solubilization of the Na+/Ca2+-
exchanger by exposing sarcolemmal membranes (2 mg/ml) to 2% cholate, 500 mM 
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NaCl, 24 mglml asolectin, 20 mM 4-morpholineethanesulfonic acid (Mes)-Tris, pH 
7.4 for 20 min on ice. Following removal of insoluble material, reconstitution was 
achieved by a sixfold dilution of the solubilized preparation with 160 mM NaCl, 20 
mM Mes-Tris, pH 7.4. This procedure resulted in a fivefold increase in specific 
activity with no change in total activity. Since that time, there have been a number 
of reports on the use of cholate to solubilize Na +/Ca2+ exchange activity from 
cardiac tissue (Hale et al., 1984; Luciani, 1984; Carpenedo et al., 1986; Vemuri and 
Philipson, 1987; Hale et al., 1988). Specific activity was typically increased four- to 
fivefold over that of native sarcolemmal vesicles. 
Here we report solubilization and reconstitution conditions which increase 
specific activity more than 30-fold over that of native sarcolemmal vesicles. 
Optimal recovery of Na+/Ca2+ exchange activities was found to occur at a 
solubilizing concentration of 1% cholate (Figure 2). The difference between this 
result and that of Miyamoto and Racker (1980) may reflect the lower protein 
concentration used here for solubilization (0.75 vs. 2.0 mg/ml). Similar values 
were obtained with and without the 20-min incubation used by Miyamoto and 
Racker (1980). Recovery of activity was found to be dependent on the extent of 
dilution with a threefold dilution resulting in optimal recovery of total activity 
(Figure 3). This result is equivalent to that of Miyamoto and Racker (1980; used a 
sixfold dilution) given that the cholate concentration after dilution was identical 
(0.33%). Presumably, the degree of dilution affects the probability for conversion of 
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Figure 2. Recovery of Na+/Ca2+ Exchange Activity Versus Cholate ConcentratiolL 
Na +-loaded sarcolemmal vesicles were solubilized with cholate as 
specified in 480 mM NaCl, 10 mM Mops-Tris, pH 7.4, 25 mg/ml 
asolectin. Insoluble material was removed by centrifugation and 
protein was reconstituted by a sixfold dilution with Buffer I and assayed 
for Na+/Ca 2+ exchange activity as described under "Materials and 
Methods" (n = 2). 
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Figure 3. Recovery ofNa +/Ca2+ Exchange Activity Versus Dilution of ChoIate-
solubilized Fraction for Reconstitution. Na +-loaded sarcolemmal 
vesicles were solubilized with 1% cholate, 480 mM NaCI, 10 mM 
Mops-Tris, pH 7.4, 25 mg/ml asolectin. Subsequent to removal of 
insoluble material by centrifugation, reconstitution was effected by 
diluting the solubilized fractions as indicated on the abscissa with 
Buffer I. Proteoliposomes were assayed for Na +/Ca2+ exchange activity 
as described under "Materials and Methods" (n = 3). 
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the mixed micellar system to proteoliposomes (e.g., see Reynolds and McCaslin, 
1989). Optimal NaCI (480 mM; Figure 4) was also found to be similar to that 
reported by Miyamoto and Racker (1980). Furthermore, in the absence of NaCl 
(KCI as a replacement) or exogenous phospholipids, Na+/Ca2+ exchange activity 
was markedly reduced (data not shown). 
Solubilization and reconstitution of the Na+/Ca2+ exchanger by use of cholate 
under the conditions described here (final concentrations of 1% cholate, 480 mM 
NaCI, 10 roM Mops-Tris, pH 7.4, 25 mg/ml asolectin with a threefold dilution for 
reconstitution) resulted in a 32.6 .. fold increase in specific activity and 202% 
recovery of total activity (Table 1). Apparent activation of exchange activity may be 
explained by a number of mechanisms including solubilization of the exchanger 
from leaky sarcolemmal vesicles followed by reconstitution into sealed 
proteoliposomes, stimulation by limited proteolysis (Philipson and Nishimoto, 
1982), reconstitution into proteoliposomes of high anionic phospholipid content 
(Hale et al., 1984; Philipson and Nishimoto, 1984; Philipson, 1984; Soldati et al. , 
1985; Vemuri and Philipson, 1987; Cheon and Reeves, 1988), or possibly by loss of 
endogenous regulators (Hale et al., 1984; Vemuri and Philipson, 1987). 
Given that anionic detergents such as cholate preclude the use of ion 
exchange chromatography (Renswoude and Kempf, 1984; Hjelmeland and 
Chrambach, 1984) and may interfere with some lectin affinity chromatography 
(Lotan et al. , 1977; Renswoude and Kempf, 1984), it is desirable to solubilize the 
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Figure 4. Recovery ofNa +/Ca2+ Exchange Activity Versus NaCI Concentration 
During Solubilization. Na +-loaded sarcolemmal vesicles were 
solubilized with 1% cholate, 10 mM Mops-Tris, pH 7.4, 25 mg/ml 
asolectin at the indicated NaCI concentrations. Proteoliposomes were 
formed by a threefold dilution of the solubilized fraction with Buffer I 
and assayed for Na+/Ca2+ exchange activity as described under 
"Materials and Methods" (n = 2). 
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TABLE 1 
Na+ /Cn2+ Exchange Activity in Sarcolemmal and Proteoliposome Preparations. 
Reconstitution Protein Recovery Total Activity Specific Activity 
(j.tg/mg SL) (nmol/seclmg SL) (nmol/mg/sec) 
Sarcolemma 1000.0 5.2 5.2 
Cholate Dilution 66.1 10.5 169.7 
CHAPS Dialysis 124.0 2.6 21.2 
CHAPS Cholate Dilution 66.1 10.2 159.8 
n-octyl .. B-D .. glucoside Cholate Dilution 75.6 10.6 177.1 
Decyl-B-D-maltoside Cholate Dilution 88.5 7.0 79.3 
Triton X-100 (0.188%) Cholate Dilution 28.5 4.2 148.6 
Triton X-100 (1.5%) Cholate Dilution 38.4 1.0 24.7 
Na+ -loaded sarcolemmal vesicles were solubilized with either 9 mM CHAPS, 40 mM n-octyl-B-D-
glucoside, 10 mM deeyl-B-D-maltosidc. 0.188% Triton X-100 or 1.5% Triton X-100 dissolved in Buffer I or with 
1 % cholate, reconstituted as indicated, and assayed for Na+/Ca2+ exchange activity as described under 
"Materials and Methods". Values represent the mean of the following number of determinations: 
sarcolemma, n = 32; cholate, n = 24; CHAPS (dialysis), n = 3; CHAPS (dilution), n = 16; n-octyl-B-D-glueoside, 
n = 3; deeyl-B-D-maltoside, n = 3; Triton X-100 (0.188%), n = 2; and Triton X-100 (1.5%), n = 2. 
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Na+/Ca2+exchanger with nonionic or zwitterionicdetergents such as those which 
have been reported previously (Soldati et al., 1985; Vemuri and Philipson, 1987; 
Cheon and Reeves, 1988; Cook and Kaupp, 1988; Philipson et al., 1988; Nicoll and 
Applebury, 1989; Durkin et al., 1990). However, reconstitution by detergent 
extraction (typically by Amberlite XAD-2 or Bio-Beads SM-2) has resulted in only 
about a four- to tenfold increase in specific activity (Soldati et al., 1985; Vemuri and 
Philipson, 1987; Cheon and Reeves, 1988; Philipson et al., 1988; Vemuri and 
Philipson, 1989). Nicoll and Applebury (1989) reported reconstitution of the rod 
outer segment Na +/Ca2+ exchanger (solubilized with CHAPS) by addition of cholate 
and asolectin followed by dilution. We found that this combination yielded a 
30.7-fold increase in specific activity and a 196% recovery of total activity (Table 1). 
Conditions for solubilization with CHAPS were initially optimized (9 mM CHAPS; 
Figure 5) using a previously described dialysis procedure (Cook and Kaupp, 1988) 
as a means of reconstitution. Recovery of total and specific activity, however, was 
quite low (Table 1). Reconstitution by cholate dilution provided a 3.9-fold greater 
recovery of total activity while specific activity was 7.5-fold higher than that 
obtained with reconstitution by dialysis (Table 1). 
At 2% cholate, the amount of asolectin solubilized was found to be less than 
50 mg/ml as visually determined after extensive sonication (medium remained 
turbid). The relationship between light scatter and asolectin concentration 
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Figure 5. CHAPS Titration Curve. Various concentrations of CHAPS, in 160 mM 
NaCI, 20 mM MOPS-Tris, pH 7.4, were used to solubilize cardiac 
sarcolemmal vesicles. Proteoliposomes were formed by dialysis (Cook et 
al., 1986) against 160 mM NaCI, 20 mM Mops-Tris, pH 7.4, 2 mM CaCl2 
followed by two changes of the same buffer without CaC1 2 at 5°C. 
Proteoliposomes were recovered by centrifugation and assayed for 
exchange activity and protein. Na+/Ca2+ exchange activity and protein 
are expressed as percent of control sarcolemma. 
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solubilized by 1 ml of 2% cholate in 800 mM NaCI, 10 mM Mops-Tris, pH 7.4 
(Figure 6). Prior to the use of cholate dilution for reconstitution of exchange 
activity solubilized with CHAPS (or other detergents), it was necessary to remove 
insoluble material from the cholate/phospholipid suspension by centrifugation 
("Materials and Methods"). Recovery of total and specific activity from cholate-
solubilized sarcolemma was unaffected by prior centrifugation of the 
cholate/phospholipid suspension to remove insoluble material (data not shown). 
In addition to CHAPS, several nonionic detergents were screened for their 
ability to effectively solubilize the exchanger using cholate dilution as a means for 
reconstitution. The concentrations of the nonionic detergents n-octyl-B-D-
glucoside and decyl-B-D-maltoside were optimized to yield the greatest recovery of 
total and specific activity using cholate dilution as a means of reconstitution. 
Detergent concentrations optimal for solubilization may in some cases affect 
proteoliposome formation by the cholate dilution technique. The critical micelle 
concentrations (cmc) for n-octyl-D-glucoside (25 mM; Hjelmeland and 
Chrambach, 1984) and decyl-D-maltoside (2.2 mM; Alpes et al., 1986) are such 
that subsequent dilution lowered the detergent concentration below its ernc 
(important for proteoliposome formation by the cholate dilution technique). 
Several groups reported use of Triton X-1oo (1-1.5%) to solubilize exchange activity 
from cardiac sarcolemma (Soldati et al., 1985; Vemuri and Philipson, 1987; Cheon 
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Figure 6. Solubility of Asolectin in 2% Cholate, 800 mM NaCI, 10 mM Mops-Tris, 
pH 7.4. A solution of 2% cholate, 800 mM NaCI, 10 mM Mops-Tris, pH 
'1.4, 50 mg/ml asolectin was sonicated to uniform suspension with a 
bath sonifier. The suspension was diluted with 2% cholate, 800 mM 
NaCI, 10 mM Mops-Tris, pH 7.4 to various asolectin concentrations as 
indicated. A portion of the suspension was cleared of insoluble material 
by centrifugation (180,000 x g; 30 min). An Aminco Bowman 
spectrophotofluorometer was used to determine 900 light scatter at 550 
nm. The relative intensity of the precleared fraction was set at 6% 
(indicated by the broken line). Relative intensity of the 50 mg/ml 
asolectin solution prior to centrifugation was set at 920/0. 
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X-I00 is quite low (0.0188%, Hjelmeland and Chrambach, 1984), solubilization of 
exchange activity at such high concentrations would undoubtedly result in poor 
proteoliposome formation by the cholate dilution technique. Therefore, we chose to 
use two concentrations of Triton X-IOO for solubilization: (1) a high concentration 
(1.5%) such as those reported above, and (2) a low concentration (0.188%) such that 
subsequent dilution would lower the detergent concentration close to its crnc. As 
anticipated, proteoliposome formation was greatly reduced when exchange 
activity was solubilized at 1.5% Triton X-100 and resulted in low recovery of total 
and specific activities (Table 1). However, solubilization at 0.188% followed by 
cholate dilution resulted in a 28.6-fold increase in specific activity, but a 19% loss of 
total activity (Table 1). Interestingly, we found that solubilization of the Na +/Ca2+ 
exchanger with the detergents listed in Table 1 differed from cholate solubilization 
in that the presence of exogenous phospholipid during solubilization was no 
longer required for preservation of activity. 
The optimal requirement for asolectin in the cholate medium depended on 
whether cholate was used for both solubilization and reconstitution or 
reconstitution alone (solubilization with CHAPS). Optimal concentrations of 15 
and 25 mg/ml (asolectin concentrations prior to preclearing) were found for the 
former and latter cases, respectively (Figure 7). The shift to a higher asolectin 
concentration with CHAPS is assumed to reflect a higher total detergent 
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Figure 7. Recovery of Na +/Ca2+ Exchange Activity versus Asolectin Concentration 
for Cholate- and CHAPS-solubilized Sarcolemma. For cholate, Na +-
loaded sarcolemmal vesicles were solubilized with 1 % cholate, 480 ml\1 
NaCI, 10 mM Mops-Tris, pH 7.4 at the specified asolectin 
concentrations. Insoluble material was removed by centrifugation and 
protein was reconstituted by a threefold dilution with Buffer I and 
assayed for Na +/Ca2+ exchange activity (., total activity; 0, specific 
activity; n = 3). For CHAPS, Na+-Ioaded sarcolemmal vesicles were 
solubilized with 9 mM CHAPS, 160 mM NaCl, 10 mM Mops-Tris, pH 7.4 
and reconstituted by cholate dilution as described under "Materials and 
Methods" where the cholate medium (prior to preclearing) contained 
varying asolectin concentrations as specified. Proteoliposomes were 
formed by a threefold dilution of the solubilized fraction with Buffer I 
and assayed for Na+/Ca2+ exchange activity ( ., total activity; 0, specific 
activity; n = 3). 
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Recovery of exchange activity upon reconstitution was found to be inversely 
related to the volume/tube centrifuged in the initial collection of the 
proteoliposomes with maximal recovery achieved at one ml or less per tube 
(Figure 8). A 50% increase in time or a 25% increase in force of centrifugation 
resulted in only a slight increase in activity recovered for larger volumes. The 
difficulty in collecting the proteoliposomes may reflect their low density due to 
residual detergent. After detergent dilution and centrifugation, the membrane 
preparation manifested little Na+/Ca2+ exchange activity suggesting leaky or 
incompletely formed vesicles. In agreement with this interpretation, recovery of 
activity, following a subsequent wash step to reduce detergent, exhibited no volume 
dependency for centrifugation and the preparation was characterized by high 
Na+/Ca2+- exchange activity. While centrifugation of very small volumes is tedious, 
it does appear necessary for the greatest recovery of activity. 
Solubilization with zwitterionic or nonionic detergents allows manipulation 
of the solubilized proteins for purification without the interference seen with ionic 
detergents such as cholate or the presence of high concentrations of exogenous 
phospholipids. However, reconstitution of exchange activity solubilized with these 
detergents resulted in relatively small increases in specific activity. Cholate and 
phospholipids, which can be added in combination after protein fractionation 
procedures, provide a simple and rapid means for reconstitution of the 
Na +/Ca24-exchanger, and also provide about a 30-fold increase in specific activity. 
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Figure 8. Recovery of Na +/Ca2+ Exchange Activity Versus the Volume of Sample 
Centrifuged After Reconstitution. N a +-loaded sarcolemmal vesicles 
were solubilized with 9 mM CHAPS, 160 mM NaCI, 10 mM Mops-Tris, 
pH 7.4. Reconstitution of the solubilized fraction was carried out by 
cholate dilution as described under "Materials and Methods". 
Proteoliposomes were pelleted using a Sorval A-125.6 rotor (230,000 x g; 
60 min) where the total volume during the initial centrifugation step 
varied between 0.6 and 9.6 ml. Centrifugation volumes during the 
washing step were held constant at 10 ml. 
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We believe that the procedure described above, optimized for the Na +/Ca2+ 
exchanger, should be applicable to some other integral membrane proteins. 
Variables that must be tailored for a particular protein include choice and 
concentration of the detergent used for solubilization. The use of a detergent for 
solubilization for purification followed by addition of cholate and dilution for 
reconstitution clearly works best when the first detergent has a high crnc (e.g., 
CHAPS, n-octyl-B-D-glucoside, decyl-B-D-maltoside; Table 1). However, the 
procedure may be applicable in those cases where sufficient solubilization is 
achieved at a low concentration of a detergent with a low crnc (e.g., 0.188% Triton 
X-IOO; Table 1). Upon selection of the first detergent and its concentration, the 
amount of lipid added with cholate should be optimized for maximal recovery of 
the protein upon reconstitution (Figure 7). Finally, the NaCI concentration of the 
medium immediately prior to dilution was clearly important for reconstitution of 
the Na +/Ca2f. exchanger (Miyamoto and Racker, 1980; Figure 4). Proteoliposomes 
were recovered when sodium was replaced by potassium but, as stated above, the 
recovery of activity was low. Although not systematically studied, the poor 
recovery upon replacement of sodium probably reflected a stabilization of this 
particular protein by sodium. In other experiments, the substitution of potassium 
for sodium in media containing the solubilized exchanger invariably led to 
substantial loss of Na+/Ca2+ exchange activity (data not shown). Thus, the salt 
selected to set ionic strength at the reconstitution step might be tailored for the 
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particular protein under study. 
CHAPTER ill 
Behavior of the Cardiac Na+/Ca2+ Exchanger in the Solubilized 
State: Rapid Purification with Recovery of High Specific Activity 
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INTRODUCTION 
Calcium movements across cardiac sarcolemma (SL) are mediated by 
Ca2+-channels, a Ca2t--ATPase and the Na+/Ca2+ exchanger (Blaustein, 1988; 
Figure 1). The Na +/Ca2+ exchanger promotes the coupled movement of sodium 
and calcium across the cell membrane in a reversible, electrogenic manner 
(Reeves and Philipson, 1989; Philipson, 1990). The protein responsible for 
Na+/Ca2t- exchange in canine cardiac tissue has been identified through a 
combination of purification, immunological and cloning approaches (Philipson et 
al., 1988; Nicoll et al., 1990). 
Structure-function studies of the Na+/Ca2+ exchanger protein will 
ultimately require optimal strategies for isolating the functionally active protein 
from tissues and from cell lines overexpressing the protein. As discussed 
previously (Philipson et ale , 1988), strategies for the purification of the Na +/Ca2+ 
exchanger are currently restricted by several considerations: a) present in cell 
plasmalemma at a low density; b) lack of selective, high affinity ligands; and c) 
requirement that solubilized fractions be reconstituted prior to assay of activity. 
We have previously reported the utility of solubilizing the cardiac Na +/Ca2+ 
exchanger with CHAPS followed by the addition of cholate and lipids for 
reconstitution (Ambesi et al., 1991e). A similar sequence was found to be effective 
for the rod outer segment (ROS) exchanger (Nicoll and Applebury, 1989). This 
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allows fractionation of proteins in CHAPS prior to use of the detergent dilution 
technique (Racker et al., 1979) for reconstitution. However,' anomalous behavior of 
the solubilized cardiac exchanger has been reported for several fractionation 
procedures. Philipson et al. (1988) found that selective elution of the cardiac 
exchanger from DEAE-Sepharose was highly detergent-dependent. Selective 
elution was not obtained when solubilization was carried out with CHAPS but was 
obtained with certain nonionic detergents (e.g., decylmaltoside). Additionally, the 
cardiac Na +/Ca2+ exchanger, in the presence of CHAPS (Philipson et al., 1988) or 
high cholate (4%; Durkin et al., 1988), binds well to wheat germ agglutinin (WGA) 
affinity supports, but little purification is achieved by elution with N-acetyl-D-
glucosamine. Rather, purification was effected by elution with nonionic 
detergents (Le., Triton X-100, Philipson et al., 1988; polyoxyethylene-9-lauryl ether, 
Durkin et al., 1988). 
Here, we report studies on the behavior of the cardiac Na +/Ca2r exchanger 
in the solubilized state with regard to three fractionation procedures. The results 
led to a sequence for the rapid purification and reconstitution of the exchanger 
with recovery of specific activities that were approximately 3.7- to 5.6-fold higher 
than previously reported (Soldati et al.,1985; Philipson et al. , 1988; Durkin et al., 
1991). The purified preparation \vas characterized by polypeptides of 75, 120 and 
140 kilodalton (kDa) upon SDS-PAGE under reducing conditions and of 140 kDa 
under nonreducing conditions. A minimal turnover number for the purified 
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preparation was calculated for a monomer of the 140 kDa protein. However, 
several results suggested the presence of multimeric complexes of the exchanger 
in the presence of detergent. 
EXPERIMENTAL PROCEDURES 
Materia1s 
WGA-Sepharose 6MB and DEAE-Sepharose were purchased from 
Pharmacia LKB Biotechnology Inc.. The TSK 5000 PW high performance liquid 
chromatography (HPLC) column and Spherogel TM TSK PWH-PRE guard column 
were obtained from Beckman Instruments Inc. and the Protein-Pak 300 sw HPLC 
column from Waters. Pepstatin A was purchased from Calbiochem Corporation, 
leupeptin from Boehringer Mannheim Biochemicals, phenylmethylsulfonyl-
fluoride (PMSF) and cholic acid from Serva Biochemicals and CHAPS from Pierce 
Chemical Corporation. All reagents for SDS-PAGE were electrophoresis grade 
and obtained from Bio-Rad Laboratories. The Centricell 60 filtration device was 
purchased from Polysciences, Inc (Warrington, PA) and the Centricon 30 
ultrafiltration apparatus was obtained from Amicon (Danvers, MA). 45CaCl2 was 
obtained from New England Nuclear. Soybean phosphatidylcholine Type II-S and 
Type IV-S were obtained from Sigma Chemical Company and treated as 
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previously described by Hale et al. (1984) and by Cook et al. (1986), respectively. All 
other chemicals were reagent grade. 
Purification of the Sarcolemma) Na+/Ca2+ Exchanger 
Unless otherwise stated, all procedures were carried out at 4°C. All buffers 
were freshly prepared and contained the following protease inhibitors: 1J.LM 
pepstatin, 1 J.LM leupeptin and 0.1 mM PMSF. Buffers were filtered (Gelman, 0.2 
J.Lm SUPOR-200) immediately prior to use. Sarcolemma enriched preparations 
from canine ventricle were obtained by modification of the procedure of 
VanAlstyne et al. (1980) as described by Ambesi et al. (1991e). Sarcolemmal 
vesicles were exposed to 160 mM NaCI, 10 mM Mops-Tris, pH 7.4 (Buffer I) for 
12-18 hours on ice (Na+-Ioading) and subsequently subjected to alkaline extraction 
(Philipson et al., 1987). Briefly, sarcolemmal vesicles (1.5 mg/ml) were diluted 
10-fold with ice cold 10 mM 3-(cyclohexylamino)propanesulfonic acid 
(Caps)-NaOH, pH 12.1, collected by centrifugation (230,000 x g, 30 min) and 
resuspended in Buffer I at 10 mg of starting sarcolemma/ml. Resuspended 
membranes were solubilized at 5 mg of starting sarcolemma/ml in 12 mM 
CHAPS, 160 mM NaCI, 10 mM Mops-Tris, pH 7.4 for 30 min with frequent 
vortexing. Insoluble material was removed by centrifugation (180,000 x g, 30 min). 
The supernatant was applied 3 times to a 1.2 x 0.6 cm DEAE-Sepharose column 
(room temperature) at a flow rate of 0.5 ml/min which had been previously 
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equilibrated with 100 ml of 9 mM CHAPS, 160 mM NaCI, 10 mM Mops-Tris, pH 
7.4, 0.12% phosphatidylcholine (Type IV-S; Buffer II). The column was washed 
with 15 ml of Buffer II (1 mVmin), and then eluted in a single step with 10 ml of 9 
mM CHAPS, 225 mM NaCI, 10 mM Mops-Tris, pH 7.4, 0.12% phosphatidylcholine 
(Type IV-S) at a flow rate of 1 mllmin. The eluent was collected on ice. The 
fraction enriched with the Na+/Ca2+ exchanger, eluted from the DEAE-Sepharose, 
was concentrated to about 500 J.1l in a Centricell 60 (30,000 Da exclusion limit; 3000 
x g, 20 min), transferred to a Centricon 30 and concentrated further (3600 x g, 30 
min) to a volume of 100-200 J,1l. The concentrated fraction was applied to TSK 5000 
PW (7.5 x 30 cm) and Protein-Pak 300sw (7.8 x 30 cm) gel filtration HPLC columns 
linked in tandem which had been equilibrated with Buffer II. The columns were 
eluted at a flow rate of 0.5 ml/min with Buffer II and 0.8 ml fractions were 
collected on ice. The fractions enriched in Na+/Ca2+ exchange activity (elution 
volume, Ve, 15.4 to 19.4 ml) were pooled. The pooled HPLC fractions were then 
concentrated in a Centricon 30 to 750 J.lI and diluted with an equal volume of 20/0 
cholate, 0.8 M NaCI, 10 mM Mops-Tris, pH 7.4, 50 mg/ml phosphatidylcholine 
(Type II·S) which had been sonicated to a uniform suspension with a bath sonifier 
(Model W185F; Heat Systems-Ultrasonics, Inc.) and cleared of insoluble material 
by centrifugation (180,000 x g, 30 min; Buffer III). This was then applied to a 1.0 
ml bed volume of WGA-Sepharose which had been equilibrated with 100 ml of 
Buffer IV (Buffer II diluted with an equal volume of Buffer III) and incubated for 
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30 min with gentle agitation at room temperature. The nonbound fraction was 
collected and the WGA-Sepharose was washed with four 1.0 ml aliquotes of Buffer 
IV. All fractions were collected on ice, reconstituted separately and then pooled. 
This constituted the purified Na+/Ca2+ exchanger preparation. 
Protein Reconstitution 
Reconstitution of solubilized proteins was performed by modifications of the 
Miyamoto and Racker (1980) procedure as described by Ambesi et ale (1991e). 
Briefly, samples for reconstitution were adjusted to final concentrations of 1% 
cholic acid, 4.5 mM CHAPS, 480 mM NaCI, 10 mM Mops-Tris, pH 7.4, 25 mg/ml 
phosphatidylcholine (Type II-S) by a 2-fold dilution of CHAPS-solubilized sample 
with Buffer III. Note that the nonbound and wash fractions collected off the 
WGA-Sepharose were already adjusted to these concentrations. After incubation 
on ice for 5 min, proteoliposomes were formed by a 3.2-fold dilution with Buffer I, 
collected by centrifugation (230,000 x g, 60 min), then washed once by resuspension 
with Buffer I and centrifugation as above. Proteoliposomes were resuspended in 
100-300 J.LI of Buffer I and used for assays of activity and protein, SDS-PAGE, 
immunoreactivity and the generation of polyclonal antibodies. 
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Assay for Na+/Ca2+ Exchanger 
Na+/Ca2+- exchange assays were carried out according to the procedure of 
Reeves and Sutko (1983) with slight modifications. Briefly, for Na+i-dependent 
45Ca2f. uptake assays, vesicles were either preloaded with Buffer I for 12-18 hours 
on ice (sarcolemma preparations) or formed in the presence of NaCI 
(proteoliposomes) trapping Na + inside. Na+/Ca2+ exchange activity was measured 
by rapidly diluting 5 JlI of Na+-Ioaded vesicles into 245 III of uptake medium 
containing 160 mM KCI, 10 mM Mops-Tris, pH 7.4, 0.5 IlM valinomycin (added as 
a 0.1 mM stock solution in absolute ethanol), 40 JlM 45CaCl2 (specific activity 
150-250 cpm/pmol) at 37°C. The reaction was terminated after 1 sec by the addition 
of 5 ml of ice-cold stop solution (160 mM KCI, 0.1 mM EGTA, 10 mM Mops-Tris, pH 
7.4). Timing was carried out using a metronome. The vesicles were filtered 
(Millipore, Type HA 0.45 Ilm) and the filter washed with 3 x 5 ml of the ice-cold 
stop solution. The 45Ca2+ content on the filters was determined by liquid 
scintillation techniques. Values for 45Ca2+ uptake were corrected by subtracting 
the amount of uptake in the absence of aNa +-gradient (reaction media contained 
160 roM NaCI instead of 160 roM KCI). 
Electrophoresis and Western Blotting 
SDS-PAGE was performed as described by Laemmli (1970) using a linear 
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4-12% gradient resolving gel and 4% stacking gel. Reconstituted samples were 
first precipitated with acetone (-20°C) and extracted with diethyl ether to remove 
excess lipid. Sample buffer contained the following protease inhibitors: 1 JlM 
pepstatin, 1 J.LM leupeptin, 0.1 mM PMSF and 0.1 mM EDTA. Solubilization (2% 
SDS; 0.5% Triton X-100) was carried out in the presence of either 100 mM 
dithiothreitol (DTT; reducing conditions) or 10 mM N-ethylmaleimide (NEM; 
nonreducing). Samples were heated to 95-98°C for 3 min. Proteins were 
visualized by silver staining according to the method of Heukeshoven and Dernick 
(1985). For immunoblots, proteins from SDS-PAGE were transferred onto 
Immobilon-P (Millipore; polyvinylidene difluoride) for 30 min at 30 volts followed 
by an additional 30 min at 100 volts using a Bio-Rad Trans-Blot Cell (plate 
electrodes). Blots were blocked in Tris-buffered saline (TBS; 150 mM NaCI, 20 mM 
Tris ... CI, pH 7.4) containing 5% nonfat milk and 2% fetal bovine serum for 1 hour at 
37°C, washed with three changes (5 min each) ofTBS, 0.1% BSA and incubated 2 
hours at room temperature with antiserum diluted 500-fold into TBS containing 
0.05% Tween-20. Blots were then washed as above and immunoreactions were 
detected by autoradiography using [125I]protein A (Huynh et al., 1985). Briefly, 
immunoblots were washed as above, followed by an additional 5 min wash in TBS, 
20% fetal bovine serum and incubated 1 hour at room temperature in TBS, 20% 
fetal bovine serum containing 0.09 J.!Ci [125I]protein Almi. Blots were then washed 
as follows: (1) 10 min in TBS, (2) 10 min in TBS, 0.1 % Triton X-lOO followed by (3) 10 
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min in TBS. Subsequently, blots were dried and exposed to Kodak X-OMAT AR 
autoradiographic fum for 1 to 7 days. 
Generation of Poly clonal Antibodies 
The Na+/Ca2+ exchanger was purified and reconstituted as described above. 
Between 50 and 75 Ilg of purified Na+/Ca2+ exchanger were emulsified with 
Freund's complete adjuvant and injected into the hind leg muscles and 
subcutaneously at multiple sites on the back of a male New Zealand white rabbit. 
Four weeks after primary immunization, the procedure was repeated except that 
Freund's incomplete adjuvant was used. Antiserum was collected ten days after 
boosting. 
Enzyme-Ilinked TmmunosorbentAssay (ELISA) 
Microtitration plates (polyvinyl chloride; 96-well plates) were coated 18 
hours at 4°C with either 0.25, 0.50 or 1.00 J.1g of canine cardiac sarcolemma diluted 
into 100 JlI of phosphate-buffered saline (PBS). The plates were washed 3X with 
PBS, 0.1% BSA and blocked 1 hour at 37°C with 250 J.ll PBS, 30/0 BSA. The plates 
were washed 3X with PBS, 0.05% Tween-20 and incubated 1.5 hours at 37°C with 
antiserum diluted (various dilutions) into 80 JlI PBS, 0.05% Tween-20, 1 % BSA. 
The plates were washed 7X with PBS, 0.05% Tween-20 and incubated 1.0 hour at 
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room temperature with goat anti-rabbit IgG-horseradish peroxidase conjugate 
diluted (lOOO-fold) into 80 ).1.1 PBS, 0.05% Tween-20, 1% BSA. The plates were 
washed 7X with PBS, 0.05% Tween .. 20 and incubated 10 min at room temperature 
with 100 J.lI 0.03% ABTS [2,2'-azinobis(3-ethylbenzthiazoline .. 6-sulfonic acid), 
diammonium salt], 0.003% H202 in 0.05 M citrate buffer, pH 4.0 and read at 414 
nm in an automated spectrophotometric micro titration plate reader. 
Protein Assays 
Protein was determined by the method of Lowry et al. (1951) for sarcolemma 
preparations and by the method of Kaplan and Pedersen (1985) for reconstituted 
proteoliposome preparations. Bovine serum albumin was used as the standard. 
RESUL1S 
The procedure developed for purification of the canine cardiac sarcolemmal 
Na+/Ca2+- exchanger is summarized in Figure 9. 
AJka1ine Extraction and Solubilization 
The use of alkaline extraction of sarcolemmal membranes, as described by 
Philipson et ale (1987), provides a quick and simple means for enriching Na+/Ca2+ 
Figure 9. 
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Canine Cardiac Sarcolemmal Preparation 
t 
Load Vesicles with 160 mM NaCl, 10 mM Mops-Tris, pH 7.4 
Wash Membranes at pH 12.1 
Solubilize with 12 mM CHAPS 
t 
DEAE-Sepharose Chromatography 
Gel Filtration HPLC 
Wheat Germ Agglutinin-Sepharose Chromatography 
+ 
Reconstitute into Proteoliposomes by Cholate Dilution 
Purification Scheme for the Canine Cardiac Na+/Ca2+ Exchanger. 
All steps were carried out in the presence of protease inhibitors (1 
J.1M pepstatin, 1 JlM leupeptin and 0.1 mM PMSF). 
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exchange activity. Alkaline extraction of sarcolemmal membranes at pH 12.1 
provided a 3-fold enrichment of Na+/Ca2+ exchange activity over control 
proteoliposomes (87-fold over SL) with 72% recovery of activity and a specific 
activity of 452 nmol/mg/sec (n = 30; Table 2). 
Previous studies (Ambesi et al., 1991e) have shown that the concentration of 
CHAPS required for optimal solubilization and recovery of Na+/Ca2+ exchange 
activity is 9 mM for a protein concentration of 0.75 mg/ml. However, solubilization 
at low protein concentrations (0.75 mg/ml) results in excessively large volumes 
upon scale-up for purification of the exchanger. In order to keep volumes at a 
minimum, we chose to solubilize at a higher protein concentration. To 
accomplish this, alkaline extracted membranes were solubilized at 5 mg of 
starting sarcolemma/ml. The concentration of CHAPS required for optimal 
solubilization and recovery of exchange activity shifted to 12 mM under these 
conditions. The correlation between detergent concentration required for 
solubilization and protein concentration has been previously noted (Hjelmeland 
and Chrambach, 1984). 
DEAE-Sepharose Chromatography 
Solubilized membranes were applied to a DEAE-Sepharose column as 
indicated under "Experimental Procedures". At 160 mM NaCI, greater than 95% 
of the applied Na +/Ca2f. exchange activity and about 50% of the solubilized protein 
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TABLE 2 
Purification of the Cardiac Na+ /01,2+ Exchanger 
Fraction Protein Recovery Total Activity Specific Activity Purification Factor 
(%) (nmol/seclmg SL) (nmol/mg/sec) 
3arcolemma 100.00 5.2 5.2 
Control Proteoliposomesa 4.75 7.1 152.3 1.0 
Alkaline Extraction 0.92 5.1 451.7 3.0 
DEAE-Sepharose 0.21 3.5 1220.5 8.0 
Gel Filtration 0.07 1.5 2917.5 19.2 
WGA-Sepharose 0.02 0.7 3765.6 24.7 
a Sarcolemmal proteins were solubilized in CHAPS and reconstituted as previously described (Ambesi et al., 
1991e). Since total exchange activity is stimulated upon solubilization and reconstitution (Hale et al., 1984; Soldati 
et al" 1985; Philipson et al., 1987), specific activities in subsequent steps are compared with control 
proteoliposomes rather than with sarcolemma. Note that alkaline extraction preceded solubilization whereas the 
last three steps followed solubilization (see text). 
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was bound (Figure 10). Increasing ionic strength to 225 mM NaCI in a single step 
eluted 82% of the applied Na+/Ca2+ exchange activity and 17% of the solubilized 
protein when compared to paired controls. This fraction was used for further 
purification of the Na+/Ca2+ exchanger. Subsequent to reconstitution, specific 
activity was increased to 1221 nmoVmg/sec, an enrichment of 235 .. fold over that of 
sarcolemma, with 69% recovery of activity (n = 8; Table 2). Increasing ionic 
strength from 225 mM to 1 M NaCI eluted additional protein (33%) and Na+/Ca~ 
exchange activity (14% of the applied activity; Figure 10). Identification of the 
proteins involved with Na +/Ca2+ exchange at this stage in the purification was not 
possible due to the presence of numerous proteins. 
Gel Filtration HPLC 
The Na+/Ca2+ exchanger enriched fraction eluted from DEAE-Sepharose 
with 225 mM NaCI was concentrated by ultrafiltration and subjected to gel 
filtration HPLC. A single activity peak eluted at a relative molecular weight of 370 
kDa (Ve = 16.2 ml; Figure 11), as determined by molecular weight standards run 
under identical column conditions (Figure 11, upper inset), and correlated well 
with the elution of a single major absorbance peak detected at Ve-16.5 rol. The 
absorbance peak detected at Ve-16.5 ml provided an indirect means for predicting 
the absolute amount of total exchange activity recovered in the purified fraction 
subsequent to WGA-Sepharose chromatography and reconstitution (Figure 11, 
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Figure 10. DEAE-Sepharose Chromatography of Alkaline Extracted, CHAPS-
solubilized Sarcolemma. Sarcolemmal membranes (10 mg) were 
alkaline-extracted, solubilized with CHAPS and applied to a 
DEAE-Sepharose column as described under tlExperimental 
Procedures". The column was washed with 10 rol of Buffer II and 
exchange activity and protein were eluted by increasing the 
concentration of NaCl. Fractions (1.0 ml) were collected, 
reconstituted into proteoliposomes and assayed for exchange activity 
and protein. Absorbance at 280 nm, ---0---; NaCI concentration, ---; 
total Na+/Ca2+ exchange activity, -. -. 
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lower inset). Fractions corresponding to peak N a + /Ca2+ exchange activity were 
subjected to SDS-PAGE and found to be enriched in proteins of 75, 120 and 140 kDa. 
Although these three proteins were found to correlate well with exchange activity 
and the major absorbance peak detected at Ve-16.5 ml, a number of minor bands 
were also detected. Reconstitution of fractions eluted between 15.4 ml and 17.8 ml 
provided an additional 2.4-fold enrichment (56l-fold over sarcolemma) with a 
specific activity of 2918 nmollmg/sec (n = 7) and 21% recovery of activity (Table 2). 
The fractions collected between 15.4 ml and 19.4 ml were used for further 
purification of the Na +/Ca2+ exchanger. 
Curiously, when fractions collected between 19.4 ml and 22 ml (largest 
absorbance peak detected) were subjected to reducing SDS-PAGE, very little or no 
protein was detected. We chose to further investigate the source of this large 
absorbance peak (Ve-20 ml). In a typical purification run, Na+/Ca2+ exchange 
activity is eluted from DEAE-Sepharose with 10 ml of 9 mM CHAPS, 225 mM 
NaCI, 10 roM Mops-Tris, pH 7.4, 0.12% phosphatidylcholine and concentrated 
approximately lOO-fold as described under "Experimental Procedures". In a 
similar manner, 10 ml of DEAE elution buffer (no protein) was concentrated 
-lOO-fold and run under identical HPLC conditions. Two peaks were detected. A 
small absorbance peak was detected at Ve-12 ml (void volume, Vo ) and a large 
absorbance peak at Ve-20 ml, similar to that seen in Figure 11. We attribute this 
peak to light scatter by detergentllipid micelles. 
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WGA-Sepharose Chromatography 
Fractions enriched in Na+/Ca2+ exchange activity, collected from the gel 
filtration HPLC columns (Ve = 15.4 to 19.4 ml), were pooled, concentrated by 
ultrafiltration to 750 Jll, diluted with an equal volume of a medium containing 
high salt, cholate and lipids (Buffer III) and incubated with WGA-Sepharose 
("Experimental Procedures"). The nonbound and wash fractions were 
reconstituted and assayed for Na+/Ca2+ exchange activity and protein and 
analyzed by SDS-PAGE. When compared to paired controls, 67% of the applied 
activity was recovered with 85% of the recovered activity nonbound and 15% eluted 
with 0.4 M N-acetyl-D-glucosamine (n = 2). The first two 1.0 ml nonbound 
fractions collected off the WGA-Sepharose were most highly enriched in Na+/Ca2+ 
exchange activity and provided a 724-fold enrichment over sarcolemma with a 
specific activity of 3766 nmollmg/sec (n = 5; Table 2). Overall recovery of activity 
was 10% compared to control proteoliposomes. SDS-PAGE revealed three major 
bands at 75, 120 and 140 kDa (Figure 12, lane 3) and trace minor proteins under 
reducing conditions. Under nonreducing conditions (Figure 12, lane 4), the 75 and 
120 kDa proteins were not detected and one major band centered at 140 kDa was 
observed. A diffuse band at -250-300 kDa was detected under both reducing and 
nonreducing conditions on silver stained gels. 
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Figure 12. Silver Stain and Western Blot Analysis of Sarcolemmal Proteins and 
the Purified Na+/Ca2+ Exchange Preparation. Sarcolemmal 
membranes and the purified Na+/Ca2+ exchange preparation were 
subjected to reducing and nonreducing SDS-PAGE as described 
under uExperimental Procedures". Proteins were either silver 
stained (lanes 1-4) or electrotransferred to Immobilon-P for western 
blot analysis (lanes 5-8). Immunoreactions of blotted proteins 
(500-fold dilution of antiserum) were detected by autoradiography 
using [125I]protein A. Molecular mass markers are shown on left. 
Silver Stain: lanes 1 and 2, 40 Jlg sarcolemmal membranes under 
reducing and nonreducing conditions, respectively; lanes 3 and 4 , 
purified N a +/Ca2+ exchange preparation (from 9 mg SL) under 
reducing and nonreducing conditions, respectively. Western Blot: 
lanes 5 and 6, 10 Jlg sarcolemmal membranes under reducing and 
nonreducing conditions, respectively; lanes 7 and 8, purified 
Na+/Ca2t- exchange preparation (from 1 mg SL) under reducing and 
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Polyclonal antibodies were developed against the reconstituted, purified 
Na+/Ca2f. exchanger preparation as described under "Experimental Procedures It. 
The antiserum was initially tested for the presence of sarcolemma-specific 
antibodies by ELISA (plates coated with either 0.25, 0.50 or 1.00 Jlg sarcolemmal 
protein per well). Immunoreactions were detected at each protein value. As 
expected, antibody sensitivity (antibody dilution giving half maximal saturation) 
decreased with decreasing sarcolemmal protein (Figure 13). 
These antibodies immunoprecipitate 97% of the Na +/Ca2+ exchange activity 
from detergent-solubilized sarcolemma (Ambesi et ale ,1991c). Figure 12 shows 
the reaction of these antibodies with the purified Na+/Ca2+ exchanger preparation 
under reducing (lane 7) and nonreducing (lane 8) conditions. Under reducing 
conditions, strongest reactions occurred at 75, 120 and 140 kDa. With longer 
exposures, minor reactions were detected at 85, 114 and -250-300 kDa. Under 
nonreducing conditions, the strongest reaction was centered at 140 kDa with 
minor reactions at 114 and -250-300 kDa. The immunoreaction seen at -250-300 
kDa was strongest under nonreducing conditions. Curiously, this band 
immunoblots relatively weakly (Figure 12, lanes 7 and 8 ), yet stains heavily with 
silver (Figure 12, lanes 3 and 4). This may be the result of poor transfer from gel to 
Immobilon-P. Whether this band is related to Na+/Ca2+ exchange or not is 
unclear, although it may represent a dimer of the 140 kDa protein. The detection 
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Figure 13. Enzyme-Linked Immunosorbent Assay. Microtitration plates (96-
well) were coated with 0.25, 0.50 or 1.00 J.Lg of sarcolemma and 
incubated with antiserum diluted 100- to 240,000-fold ("Experimental 
Procedures"). Immunoreactions were detected with horseradish 
peroxidase-conjugated anti-rabbit IgG; color development was 
quantitated spectrophotometrically. 
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of multimers of certain integral membrane proteins upon SDS-PAGE has been 
well documented (e.g., rhodopsin; see Molday and Molday, 1979; De Grip et ale , 
1980; Weiss et al., 1988). 
Figure 12 also shows immunoreactions of sarcolemmal proteins under 
reducing (lane 5) and nonreducing (lane 6) conditions. Major reactions under 
reducing conditions were nearly identical to those seen in the purified exchanger 
preparation and occurred at 75, 120 and 140 kDa with minor reactions seen at 85 
and 114 kDa. Immunoreaction in the region of -250-300 kDa, however, was not 
detected. Under nonreducing conditions, the major reaction was centered at 140 
kDa. 
DISCUSSION 
We report here fractionation procedures for purifying the cardiac 
sarcolemmal Na +/Ca2+ exchanger and the development of polyclonal antibodies 
which immunoprecipitate exchange activity. Steps in the purification scheme 
include alkaline-extraction of sarcolemmal membranes followed by solubilization 
with CHAPS, DEAE-Sepharose chromatography, gel filtration HPLC, addition of 
salt, cholate and lipids and WGA-Sepharose chromatography. Combined in 
series, these steps provide a 724-fold enrichment in exchange activity over 
sarcolemma (Table 2) and yield three major proteins of 75, 120 and 140 kDa upon 
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SDS-PAGE under reducing conditions and one major band centered at 140 kDa 
under nonreducing conditions (Figure 12). These data are consistent with the 
recently proposed hypothesis that proteins of 70, 120 and 160 kDa are all involved 
with Na+/Ca2+ exchange (Philipson et ale , 1988; Vemuri et al., 1990; Nicollet al., 
1990) with the exception of minor differences in molecular masses. That is, on our 
gels, proteins of 75, 120 and 140 kDa correlate with exchange activity. This is 
further supported by the results obtained using polyclonal antibodies (provided by 
K. D. Philipson; Philipson et al., 1988) which recognized proteins of 75, 120 and 140 
kDa. 
We found that exchange activity solubilized with CHAPS readily binds to 
DEAE-Sepharose in 160 mM NaCl. Selective elution of exchange activity was 
observed when the ionic strength was increased to 225 mM NaCl. Exchange 
activity was found to elute at lower ionic strength (180 mM NaCI), but occurred at a 
slower rate resulting in large elution volumes. These results differ from those of 
Philipson et ale (Philipson et al., 1988) where Na +/Ca2+ exchange activity was 
reported to elute in parallel with all protein. There are several possible reasons for 
the discrepancy. In the separation reported here, the solubilized preparation and 
column equilibration and elution buffers contained 9-12 mM CHAPS (at or above 
the cmc; Hjelmeland, 1980). A concentration of 3 mM CHAPS resulted in elution 
of exchange activity in the void volume from the size exclusion columns (data not 
shown) which is consistent with protein aggregation. 
77 
The addition of phospholipids at low levels ("Experimental Procedures tt ) 
may also contribute to reducing protein-protein interactions and aid protein 
separation. We found that the inclusion of phospholipids in the equilibration and 
elution buffers was required for maximal recovery of exchange activity. While 
omission of phospholipids resulted in recovery of activity below 25% from the ion 
exchange step, recovery of activity from all fractions approached 100% with the 
addition of phospholipids. Nicoll and Applebury (1989), working with the ROS 
Na+/Ca2t- exchanger, also found that the addition of phospholipids was required 
for the preservation of exchange activity during column chromatography. The 
absence of phospholipids at the DEAE-chromatography step may account for the 
high degree of inactivation reported to occur at this step (Philipson et al., 1988). 
We also observed an inverse relation between recovery of activity and the volume 
used to wash the column prior to elution at 225 mM NaCl. Loss of activity with 
increased wash volume may be the result of a gradual leaching of exchange 
activity off the column (activity can be detected in all wash fractions), inactivation 
of the exchanger or both. 
The addition of phospholipids to the gel filtration HPLC running buffer was 
also required for maximal recovery of exchange activity. In the absence of 
phospholipids, recovery of activity fell below 25% while in the presence of 
phospholipids, recovery of activity from all fractions approached 100%. Gel 
filtration HPLC of the exchanger-enriched fraction obtained from the 
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DEAE-Sepharose column provided 561-fold enrichment of exchange activity over 
sarcolemma. 
Although Na+/Ca2+ exchange activity solubilized with CHAPS was quite 
readily taken up by WGA-Sepharose, little or no selective elution of exchange 
activity could be achieved with the competing sugar, N-acetyl-D-glucosamine. 
These results are in agreement with previous reports (Philipson et al., 1988; 
Durkin et al., 1988). Recently, a less conventional approach, involving the use of 
nonionic detergents to elute exchange activity from immobilized wheat germ 
agglutinin, has been reported (Philipson et al., 1988; Durkin et al., 1988). 
Experiments in this laboratory suggested that WGA-Sepharose binds very little 
exchange activity in the presence of low cholate, a high concentration of 
phospholipids and high ionic strength, but retains the ability to bind several 
sarcolemmal proteins. These conditions were incorporated into the purification 
scheme and used to remove much of the remaining protein contaminants to yield 
three proteins of 75, 120 and 140 kDa under reducing conditions and one protein 
centered at 140 kDa under nonreducing conditions (Figure 12). 
The specific activity of our most enriched preparation (3766 nmol/mg/sec) is 
approximately 3.7- to 5.6-fold higher than previously reported values (Soldati et 
al., 1985; Philipson et al., 1988; Durkin et al., 1991). This may be due in part to the 
method of reconstitution. Reconstitution of solubilized sarcolemmal proteins by 
modification of the procedure of Miyamoto and Racker (1980) as described by 
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Ambesi et ale (1991e) provides a 30-fold enrichment of exchange activity over 
sarcolemma as compared to the -5-fold enrichment reported for reconstitution by 
detergent extraction over Bio-Beads SM-2 (Philipson et al., 1988). However, we 
must caution that variability exists from laboratory to laboratory in the details of 
Na+/Ca2+- exchange assays (e.g., concentration of 45Ca2f. used) and, in particular, 
the assays used to measure protein in proteoliposome preparations. 
A turnover number for the cardiac Na+/Ca2+ exchanger can be determined 
from initial velocity conditions at 40 J.LM [Ca2f.]o (approximates Vmax conditions). 
The specific activity of the purified Na+/Ca2+ exchanger is 3766 nmollmglsec (Table 
2). If the cardiac Na+/Ca2+ exchanger is a single polypeptide of 140 kDa, then the 
apparent turnover number at 37°C is 527 Ca2+s .. 1• The actual turnover number is 
likely to be higher since the exchanger was not purified to homogeneity and some 
degree of inactivation is expected. There remains some uncertainty as to whether 
the presence of the 75 or 120 kDa proteins (SDS·PAGE, reducing conditions) 
reflects the active Na+/Ca2+ exchanger, although chymotrypsin experiments 
reported by Philipson et ale (1988) suggest that they do. Since the 75 and 120 kDa 
proteins appear to arise from the reduction of disulfide bonds (Philipson et ale , 
1988; Ambesi et al., 1991e; Figure 12), the question is whether or not the nicked 
version of the 140 kDa protein retains activity. 
If the active Na+/Ca2+ exchanger consists of multiples of the 140 kDa protein 
(dimer, trimer, etc.), then the turnover number may increase by a factor equal to 
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the number of monomers per active exchanger. Thus, a functional Na+/Ca2+ 
exchanger consisting of two 140 kDa proteins (dimer) could have a turnover 
number of about 1050 Ca2+ s-1 which is consistent with the estimate of 1000 Ca2+ S-l 
by Cheon and Reeves (1988) using indirect methods. This value, however, falls 
short of the 2500 Caat- s-1 reported by Niggli and Lederer (1991) using 
electrophysiological techniques on intact cardiac myocytes. While molecular 
weights of membrane proteins predicted by size exclusion chromatography must 
be used with caution (LeMaire et al., 1986), the elution profile in Figure 11 did 
suggest a large discrepancy in size from that observed with SDS-PAGE (i.e., 370 
versus 140 kDa). Hale et ale (1988), using cholate solubilized bovine sarcolemma, 
reported a minimum size of 224 kDa for the exchanger based on size exclusion 
chromatography. We also observed immunoreactivity in the region of -250-300 
kDa on immunoblots of the purified preparation. These data are consistent with 
the hypothesis that the functional exchanger can exist as a multimeric complex in 
the solubilized state. Whether the complex is a homomultimer or heteromultimer 
remains unknown. More intriguing is the question of whether such complexes 
exist in the lipid bilayer. In this regard, Hale et ale (1988) reported a minimal size 
of 226 kDa for the exchanger in frozen bovine cardiac sarcolemma based on 
radiation inactivation-target size analysis. 
CHAPTER IV 
Na+/Ca2+ Exchanger: Protein and Proteolytic Fragments 
in Cardiac Sarcolenuna 
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INTRODUCTION 
Nicoll et ale (1990) recently reported the isolation of a eDNA clone for the 
canine cardiac Na+/Ca2+ exchanger. The cDNA was characterized by an open 
reading frame encoding a 108 kDa protein including a potential NH2 -terminal 
signal sequence and six potential glycosylation sites. Immunoblots of canine 
sarcolemmal proteins, however, reveal a more complex pattern when probed with 
polyclonal antibodies raised against purified Na+/Ca2+ exchange preparations 
(Philipson et al., 1988; Vemuri et al., 1990; Ambesi et al., I991c) or against a 
peptide from the deduced amino acid sequence (Nicoll et al., 1990). Under 
reducing conditions, three proteins of 70-75, 120 and 140-160 kDa manifest 
immunoreactivity. Under nonreducing conditions, a protein of 140-160 kDa was 
found to be immunoreactive. Similar profiles have been observed for the purified 
exchanger by silver stain and immunoblots (Philipson et al., 1988; Ambesi et ale , 
I99Ic). 
The origin of the three proteins is unclear. They might arise in one of 
several ways including: a) through differential proteolytic processing of a 
precursor or parent protein; or b) through proteolysis during tissue processing for 
the isolation of sarcolemma or microsomal preparations. This paper is focused on 
these two possibilities. Polyclonal antibodies, raised against the purified cardiac 
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Na+/Ca2+ exchanger, were antigen purified (i.e., from each of the three proteins) 
and then tested for their ability to immunoprecipitate exchange activity and to 
cross-react with the other two proteins. In addition, the profile under reducing 
conditions was compared for isolated membrane preparations and isolated 
cardiac cells maintained in culture. Use of the latter minimized the time of 
processing prior to electrophoresis. The results suggested that the 70-75 and 120 




Pepstatin A was purchased from Calbiochem, leupeptin from Boehringer 
Mannheim Biochemicals, PM SF from Serva Biochemicals and CHAPS from 
Pierce Chemical Corporation. Protein A-Sepharose 6MB was obtained from 
Pharmacia. All reagents for SDS-PAGE were electrophoresis grade and obtained 
from Bio-Rad Laboratories. The Centricell 60 filtration device was purchased from 
Polysciences, Inc. 45CaCl2 was obtained from New England Nuclear. Soybean 
phosphatidylcholine Type II-S was obtained from Sigma and treated as previously 
described (Hale et al., 1984). All other chemicals were reagent grade. 
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Purification of the Na+/Ca2+ Exchanger and Assays 
Isolation of sarcolemmal preparations from canine cardiac ventricle, 
purification and reconstitution of the Na+/Ca2+ exchanger, assays for activity, SDS-
PAGE and western blots were carried out as previously described (Ambesi et al., 
1991c). 
Isolation of Canine Ventricular Myocytes 
Canine ventricular myocytes were isolated by collagenase perfusion of a 
section of the free wall of the left ventricle via a branch of the left circumflex artery 
according to the procedure of Urabe et ale (1991) and were obtained from R. L. 
Kent. In one experiment, the cells were allowed to settle for 5 min. The 
suspension above the settled cells (cell debris and round cells) was removed and 
the procedure was repeated twice. To the settled cells, an equal volume of 2X 
Laemmli buffer was added (final 2% SDS, 0.5% Triton X-I 00, 100 mM DTT, 1JlM 
pepstatin, 1 JlM leupeptin, 0.1 mM PMSF, 0.1 mM EDTA). The sample was 
vortexed, heated 3 min at 95-98° and electrophoresed immediately. In a second 
experiment, the cells were maintained in culture for -20 hours on laminin~oated 
culture plates in serum-free Medium 199 (GIBCO BRL) culture media containing 
penicillin (100 U/ml), streptomycin (0.1 mg/ml) and gentamicin (0.25 mg/ml). Rod 
shaped cells comprised -50-80% of the cell population. Culture plates were 
washed with PBS (3 x 4 ml) and the cells were gently removed with a rubber 
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policeman into 2 ml of PBS and allowed to settle. The settled cells were treated for 
SDS-PAGE as above and electrophoresed immediately (-30 min total processing 
time). Electrophoresed samples were transferred onto Immobilon-P and tested 
for immunoreactivity (500-fold dilution of antiserum). Immunoreactions were 
detected by autoradiography using [l25I]protein A (Huynh et ale , 1985). 
Preparation of Microsomal Fractions 
Canine kidney and bovine, porcine and rat ventricular tissue was minced, 
suspended in 5 volumes of 160 mM NaCl, 20 mM Mops-Tris, pH 7.4 and 
homogenized in a Potter Elvehjem vessel. Homogenates were centrifuged at 8500 x 
g for 15 min and the pellets discarded. The supernatants were centrifuged 
(100,000 x g, 60 min) and the pellets (microsomes) were resuspended in 1-2 ml of 
160 mM NaCl, 20 mM Mops-Tris, pH 7.4. Microsomes were frozen in liquid 
nitrogen and stored at -70°. 
Tmmunoprecipitation ofNa+/Ca2+ Exchange Activity 
Protein A-Sepharose 6MB (0.2 ml) was washed with 4 x 2 ml of MAPS II 
Binding Buffer (Bio-Rad) and incubated for 30 min at room temperature (gentle 
agitation) with either 0.5 ml of antiserum or 0.5 ml of preimmune serum diluted 
with an equal volume of MAPS II Binding Buffer. The protein A-Sepharose beads 
were washed as above. Sarcolemmal membranes (150 Ilg) were alkaline-extracted 
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(Ambesi et al., 1991c), solubilized in 9 mM CHAPS, 160 mM NaCI, 10 mM 
Mops-Tris, pH 7.4 as previously described (Ambesi et al., 1991e) and incubated 
with the IgG-protein A-Sepharose complex for 30 min at room temperature with 
gentle agitation. An aliquot of the supernatant was removed and reconstituted 
(Ambesi et al., 1991e) and Na+/Ca2+ exchange activity was measured. 
Antigen Purification of Antibodies 
Sarcolemmal proteins were subjected to preparative SDS-PAGE (290 J.Lg 
protein added to each of 2 polyacrylamide gels) and transferred onto Immobilon-P. 
The portions of the blot which contained the molecular weight markers were 
removed and stained for protein by immersion into 0.1% Naphthol Blue Black 
(w/v), 45% MeOH (v/v), 10% glacial acetic acid (v/v) for 10 min with rocking. The 
blot was destained with multiple water washes. Vertical strips (0.5 cm in width; 
taken adjacent to the molecular weight markers) were cut from the blot and tested 
for immunoreactivity with antiserum (detection with goat anti-rabbit 
IgG-horseradish peroxidase conjugate). The remainder of the blot was stained 
for total protein with Naphthol Blue Black. Subsequently, the blot was realigned 
and divided into 20 horizontal strips, each representative of a particular antibody 
binding region or molecular weight range using the immunoblots and Naphthol 
Blue Black-stained proteins as guides. The strips were blocked in TBS (150 roM 
NaCl, 20 mM Tris .. Cl, pH 7.4) containing 5% nonfat milk and 2% fetal bovine 
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serum for 1 hour at 37°, washed 3 x 5 min with TBS and incubated in a 500-fold 
dilution of antiserum in TBS containing 0.05% Tween-20 for either 2 hours at room 
temperature or 12-18 hours at 5°. Subsequently, the strips were washed as above, 
separated and the bound antibodies were eluted in 10 ml of 0.5 M NaCI, 0.2 M 
Glycine-HCI, pH 2.8, 100 Jlg/ml BSA for 10 min at room temperature. The strips 
were removed, washed as above, blocked in TBS containing 5% nonfat milk and 2% 
fetal bovine serum for 15 min at room temperature and the procedure repeated 
(each repeat = one cycle). The eluted antibodies were adjusted to pH 8.0 by addition 
of 650 JlI of 2 M Tris-base. Antibodies eluted from multiple cycles for each strip 
were pooled, concentrated to about 500 J.LI in a Centricell 60 (30,000 Da molecular 
weight cut-off) and tested for the ability to immunoprecipitate Na +/Ca2+ exchange 
activity (5 cycles) and react with sarcolemmal proteins on immunoblots (3 cycles). 
Protein Assay 
Protein was determined by the method of Lowry et ale (1951) for sarcolemma 
and microsomal preparations. Bovine serum albumin was used as the standard. 
RESUL'IS 
Immunoprecipitation ofNa+/Ca2+ Exchange Activity 
Antibodies from antiserum raised against the purified Na +/Ca2f. exchanger 
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preparation or preimmune serum (Ambesi et al., 1991c) were bound to protein 
A-Sepharose 6MB and incubated with solubilized, alkaline-extracted sarcolemma 
as described under "Experimental Procedures". The supernatant was 
subsequently reconstituted and assayed for Na +/Ca2t exchange activity. While 
preimmune serum had little or no effect on recovery of activity, the antiserum 
immunoprecipitated 97.4 ± 1.3% (values at 10 min; n = 4) of the Na+/Ca2+ exchange 
activity when compared to preimmune serum (Figure 14). Furthermore, 
Na+/Ca2+- exchange activity was immunoprecipitated in a concentration-dependent 
manner with 50% maximal effect at 20 J..Ll antiserum per mg sarcolemma (Figure 
14, inset). 
Antigen Purification of Antibodies 
Sarcolemmal proteins were subjected to SDS-PAGE and transferred to 
Immobilon-P. Antibodies were bound to and eluted from specific protein regions 
as described under "Experimental Procedures". The antigen-purified antibodies 
were tested for their ability to immunoprecipitate Na+/Ca2+ exchange activity 
(Figure 15) and react with sarcolemmal proteins under reducing and 
nonreducing conditions (Figure 16). Antibodies eluted from the 75, 120 and 140 
kDa proteins immunoprecipitated 92%, 91% and 83% (n = 2), respectively, of the 
Na+/Ca2+- exchange activity as compared to preimmune serum (Figure 15). In 
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Figure 14. Immunoprecipitation ofNa +/Ca2+ Exchange Activity. Sarcolemmal 
membranes (150 J,lg) were alkaline extracted (Ambesi et al., 1991c) and 
solubilized with 9 mM CHAPS, 160 mM NaCI, 10 mM Mops ... Tris, pH 
7.4 as previously described (Ambesi et al., 1991e). The solubilized 
fraction was either reconstituted directly or incubated 30 min with JgG 
(from preimmune or immune serum) immobilized onto protein 
A-Sepharose as described under "Experimental Procedures". An 
aliquot of the supernatant was removed and reconstituted. Calcium-45 
uptake into proteoliposomes in the presence of an outwardly directed 
sodium gradient was determined as a function of assay time at 370 
(n=2). Inset: Recovery of Na+/Ca2+ exchange activity versus volume of 
antiserum incubated with protein A-Sepharose. 
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Figure 15. Antigen Purification of Antibodies: Immunoprecipitation ofNa +/Ca2+ 
Exchange Activity. Antibodies were antigen purified as described 
under "Experimental Procedures". Antibodies, eluted from each of the 
20 strips (5 cycles), where each strip represents a particular antibody 
binding region or molecular mass range as indicated by the western 
blot shown above, were tested for the ability to immunoprecipitate 
exchange activity. Each bar on the graph represents the degree of 
immunoprecipitation of Na+/Ca2+ exchange activity achieved with the 
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Figure 16. Antigen Purification of Antibodies: Immunoreactions With 
Sarcolemmal Proteins. Antibodies were antigen purified as described 
under "Experimental Procedures" (3 cycles), diluted into 5 ml of TBS 
containing 1% BSA, 0.05% Tween-20, and tested for the ability to react 
with sarcolemmal proteins (10 J.lg) under reducing (A) and 
nonreducing (B) conditions. The number below each lane corresponds 
with the strip from which antibodies were eluted as shown in Figure 
15 (e.g., lanes 6, 8 and 14 represent immunoreactions seen with 
antibodies eluted from the 140, 120 and 75 kDa proteins, respectively). ' 
Control lanes (C) represent immunoreactions of sarcolemmal proteins 
with whole antiserum (500-fold dilution). Immunoreactions were 
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Figure 16. Figure legend on previous page. 
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30% and 37% (n=2) of the Na +/Ca2+- exchange activity, respectively. 
ImmuDoprecipitation with antibodies eluted from nonspecifically bound sites 
(regions exhibiting no detectable immunoreactivity on immunoblots) averaged 6% 
(n=2) when compared to preimmune serum. 
Antibodies eluted from each of the three major proteins (75, 120 and 140 
kDa; strips 14, 8 and 6, respectively) were found to cross-react with each of the 
other two proteins as well as the minor 85 and 114 kDa proteins under reducing 
conditions (Figure 16A). Furthermore, antibodies eluted from the 114 and 85 kDa 
proteins cross-reacted with each of the three major proteins. An identical profile 
was observed for nonreducing conditions with the strongest reaction seen at 140 
kDa (Figure 16B). 
ImmunoreactioDS with Isolated Canine Ventricular Myocytes 
Polyclonal antibodies generated against the purified cardiac Na +/Ca2+ 
exchange preparation (Ambesi et al., 1991c) were tested for immunoreactivity 
against isolated canine ventricular myocytes which were maintained in culture 
for 20 hours prior to electrophoresis (Figure 17). Under reducing conditions, a 
very intense reaction with the 140 kDa protein was found. The 120 kDa protein was 
not detected while only small amounts of the 75 kDa protein (relative to the 140 kDa 
protein) were observed. Identical results were observed when the cells were used 




Figure 17. Immunoreactions With Isolated Canine Ventricular Myocytes. 
Canine ventricular myocytes were isolated as previously described 
(Urabe et ale , 1991) and maintained in culture for -20 hours. Culture 
plates were rinsed and ventricular myocytes were gently removed with 
a rubber policeman into 2 ml of PBS, allowed to settle, solubilized with 
electrophoresis sample buffer and subjected to SDS-PAGE 
("Experimental Procedures tt). Proteins were transferred onto 
Immobilon-P and tested for immunoreactivity (500-fold dilution of 
antiserum). Immunoreactions were detected by autoradiography 
using [125I]protein A. Lane 1, 200 ng canine cardiac sarcolemma; lane 
2, -7500-12,500 ventricular myocytes. 
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for isolated membranes and isolated cells reflects the quiescent state of the 
cultured cells prior to SDS-PAGE. 
Tmmunoreactions with Canjne Kidney and Bovine, Porcine and Rat Heart 
and Microsomes 
In bovine, porcine and rat heart microsomes, the polyclonal antibodies 
generated against the purified canine cardiac Na+/Ca2+ exchange preparation 
(Ambesi et ale , 1991c) were found to react with proteins that appeared to be 
comparable to the 120 and 140 kDa proteins seen in canine cardiac sarcolemma 
(Figure 18). Although proteins of comparable molecular weight were detected in 
canine kidney microsomes, immunoreactivity with these proteins was greatly 
reduced. Greatest variability in the immunoreactive patterns among the 
microsomal fractions occurred in the 75 kDa region. While bovine and porcine 
heart microsomes exhibited reactivity in the 75 and 85 kDa regions, canine kidney 
and rat heart microsomes did not. In addition, there were variations among the 
microsomal fractions in the number, relative amounts and molecular weights of 
the minor immunoreactive proteins detected. 
DISCUSSION 
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Figure 18. Western Blot of Canine Cardiac Sarcolemma and Canine Kidney and 
Bovine, Porcine and Rat Heart Microsomes. Microsomal fractions 
were prepared as described under "Experimental Procedures", 
subjected to reducing SDS-PAGE and transferred onto Immobilon-P. 
Western analysis was carried out using a 500-fold dilution of 
antiserum and immunoreactions were detected by autoradiography 
using [125I]protein A. Molecular weight markers are shown on the 
left. Lane 1, 0.5 Jlg canine cardiac sarcolemma; lane 2, 10 Jlg canine 
kidney microsomes; lane 3, 10 J,lg bovine heart microsomes; lane 4, 10 
J,lg porcine heart microsomes; lane 5, 10 J.Lg rat heart microsomes. 
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cardiac N a +/Ca2+ exchanger is characterized by three protein bands that are 
related to each other. Philipson et ale (1988) fIrst reported that the 70 and 120 kDa 
proteins share common epitopes for immunoblotting by use of antigen-purified 
antibodies. Subsequently, Nicoll et ale (1990) reported that antibodies generated 
against a synthetic peptide constructed from the deduced amino acid sequence 
(amino acids 680 .. 694), recognize the three proteins on immunoblots. This 
suggests that all three bands contain this segment of amino acids which is located 
in the COOH-terminus half of the deduced sequence (i.e., total length of 970 amino 
acids; Nicoll et al., 1990). Durkin et ale (1991) recently reported that the NH~ 
terminal sequences of comparable 120 and 160 kDa proteins from bovine cardiac 
sarcolemma are identical. As shown above, antibodies, antigen-purified from 
each of the three major proteins, were found to cross-react with each of the other 
two prominent proteins on immunoblots, as well as the minor 85 and 114 kDa 
proteins (Figure 16), and to immunoprecipitated 83-92% of the exchange activity 
(Figure 15). Thus, the three proteins not only contain common epitopes for 
immunoblotting but also contain common epitopes necessary for 
immunoprecipitation of exchange activity. 
A straightforward interpretation of the profiles observed for reducing and 
nonreducing conditions is that much of the exchanger protein is nicked by 
proteolysis but is held together in the sarcolemma (and upon solubilization under 
nondenaturing conditions) by disulfide bonds and hydrophobic interactions. With 
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regard to this possibility, Philipson et al. (1988) showed that the 70 kDa protein 
could result from proteolysis of the 120 kDa protein by treatment with 
chymotrypsin. On the other hand, they were unable to alter the profile seen under 
reducing conditions by the inclusion of PMSF in the media used for purification. 
Likewise, we found that the pattern of three proteins was not altered by the 
inclusion of pepstatin, leupeptin and PMSF in media used for isolation of 
sarcolemma and purification of the Na+/Ca2+ exchanger (data not shown). 
Nonetheless, one or more enzymes unaffected by these inhibitors could have 
caused the modifications. 
The isolation of sarcolemma preparations in this laboratory takes 
approximately eight hours. The isolation of microsomal preparations, which 
yielded similar profiles on SDS-PAGE under reducing conditions (Figure 18), took 
approximately two hours. In an attempt to reduce the chance for proteolytic 
breakdown during processing, and to minimize contamination by other cell types 
(e.g., endothelial cells and nerve terminals), an experiment was carried out using 
isolated canine ventricular myocytes maintained in culture. Total elapsed time 
between removal of the cells from culture plates and application to the gel was -30 
min. Immunoblots of the cells revealed a profile that is clearly different from that 
for isolated membrane preparations (Figure 17). This profile suggested the 
following conclusion: The 140-160 kDa protein is the parent protein of the cardiac 
Na+/Ca2+ exchanger; much of this protein is nicked by proteolytic enzymes during 
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processing for membrane preparations which gives rise to the 70-75 kDa and 120 
kDa proteins and, possibly, to other fragments observed under reducing SDS-
PAGE. The results do not eliminate the possibility that some nicking occurs in 
vivo since a small amount of the 75 kDa protein was always present. However, the 
75 kDa protein could have been produced during the 30 min processing or could 
reflect the presence of some nonviable cells on the culture plate. 
Durkin et ale (1991) suggested that the 160 kDa protein from bovine cardiac 
sarcolemma could be an artifact of sample preparation for SDS-PAGE. They 
observed that the intensity of the 160 kDa protein increased while the intensity of 
the 120 kDa protein decreased when the samples were boiled. We compared 
heating at 37° for 30 min to heating at 95-98° for three min (the latter routinely 
used; "Experimental Procedures U ) for sample preparation. Heating at 37° 
eliminated the 140 kDa protein, reduced the 120 kDa protein to trace amounts, was 
associated with the appearance of a 114 kDa protein as the major band, and 
converted the 75 kDa protein to a 70 kDa protein (data not shown). This downward 
shift in molecular weights was in the direction expected for proteolysis since 
heating at 95-98° should favor denaturation of most proteolytic enzymes. 
The 70-75 and 120 kDa fragments are, therefore, concluded to be present in 
the 140-160 kDa protein that is observed under nonreducing conditions. The 70-75 
kDa band could include both halves of the 140-160 kDa parent protein due to a nick 
in the middle of the protein. On the other hand, the remainder of the parent 
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protein that should be associated with the 120 kDa fragment (20-40 kDa) was not 
observed under reducing conditions. Presumably, the missing fragment was 
present in the preparation since the parent protein, but not the 120 kDa protein, 
was observed under nonreducing conditions. Thus, under reducing conditions, 
the missing fragment could have been lost due to aggregation (failure to penetrate 
the resolving gel) or to multiple nicks (ran off the resolving gel). Alternatively, the 
antibodies may not have recognized this fragment on immunoblots. 
There is evidence that the nicked protein manifests exchange activity. 
Philipson et ale (1988) treated purified Na+/Ca2+ exchange preparations with 
chymotrypsin to the point that severe downward shifts in molecular weights of the 
proteins were observed without changes in Na+/Ca2+ exchange activity. Similarly, 
we have noted variations in the relative intensities of the 75, 120 and 140 kDa 
proteins on immunoblots of sarcolemma preparations that have no obvious 
correlation with the Na+/Ca2+ exchange activity of these preparations. The relative 
exchange activities of the nicked versus the intact Na+/Ca2+ exchanger protein, 
however, remain unknown. 
The major implication of this study is that the active Na +/Ca2+ exchanger in 
cardiac tissue probably exists as a monomer or, possibly, multimer (Ambesi et al., 
1991c) of an intact, non-nicked protein. If so, the activation of exchange activity by 
treatment with proteinases seen in vitro (Philipson and Nishimoto, 1982b) may not 
reflect a means by which the exchanger is regulated in vivo. 
CHAPTER V 
Effect of Poly clonal Antilxxlies 
on the Cardiac Sodium/Calcium. Exchanger 
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We have previously reported the purification of the cardiac sodium/calcium 
exchanger from canine myocardium and the generation of polyclonal antibodies 
against the purified exchanger (see chapter III). The polyclonal antibodies 
immunoprecipitated 97% of the sodium/calcium exchange activity from detergent-
solubilized sarcolemma (Figure 14) and reacted with prominent proteins of 75, 120, 
and 140 kDa (reducing conditions; Figure 12) on immunoblots of the purified 
exchanger. Only one major protein, centered at 140 kDa, was detected under 
nonreducing conditions. Subsequently, antibodies against the 75, 120, and 140 kDa 
proteins were antigen-purified and found to immunoprecipitate 92, 91, and 83% of 
the exchange activity, respectively (Figure 15). Furthermore, the antigen ... purified 
antibodies exhibited cross-reactivity with each of the other two prominent proteins 
(Figure 16). These data are consistent with those reported by Philipson et ale 
(1988), with the exception of minor differences in the molecular weights reported, 
and suggest that the three proteins are immunologically related and that all are 
related to the cardiac sodium/calcium exchanger. 
The purpose of the present study was to determine the effect of these 
antibodies on sodium/calcium exchange activity manifested by sarcolemmal 
vesicles (70% sealed RIO; 1-12% sealed lID; remainder leaky) from canine 
ventricle. The vesicles were exposed to increasing concentrations of affinity-
purified IgG from preimmune or immune serum. Antibodies from the immune 
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serum stimulated exchange activity 3.5-fold in a dose-dependent manner with half-
maximal stimulation at 0.5 Jlg IgG/Jlg sarcolemmal protein (Figure 19). 
Conversely, IgG from preimmune serum had little or no effect between 0.01 and 10 
J.1g IgG/Jlg sarcolemmal protein. A separate experiment was carried out to test 
further whether the stimulation observed with IgG from immune serum (anti-
NCX) was specific (Figure 20). Four IgG fractions were tested: (1) from the rabbit 
that was subsequently immunized against the sodium/calcium exchanger 
(preimmune); (2) anti-NCX; (3) from a rabbit immunized against total 
sarcolemmal proteins (anti-SL); and (4) from a rabbit immunized against a 
prominent sarcolemmal protein of 82 kDa enriched by a protease treatment (anti-
82; Hale et al., 1984). Exposure to 3 Jlg IgG/J..lg sarcolemmal protein showed that 
the preimmune and the anti-82 fractions caused an increase in sodium/calcium 
exchange activity of 50 and 46%, respectively, whereas the anti-NCX increased 
activity by 184% (inset, Figure 19). Interestingly, the anti-SL caused nearly as 
much of an increase (145%) as the anti-NCX but neither the anti-SL nor anti-82 
sera were able to immunoprecipitate sodium/calcium exchange activity from 
solubilized sarcolemma. Eadie-Hofstee plots suggested that the stimulation by 
anti-NCX and anti-SL was due to a small increase in V max and a larger decrease 
in the Ko.5 for [Ca2+] (Figure 20). 
Clearly these IgG fractions are capable of causing some nonspecific 
stimulation of sodium/calcium exchange activity (results with preimmune and 
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Figure 19. Effect of Poly clonal Antibodies on Sodium/Calcium Exchange Activity. 
Sodium-loaded (160 mM NaCI, 10 mM Mops-Tris, pH 7.4) 
sarcolemmal vesicles were exposed for one hour at 370 to varying 
concentrations of affinity-purified IgG from preimmune or immune 
(anti-NCX) serum and assayed for exchange activity (n = 1-4). Inset: 
Sarcolemmal vesicles were exposed to affinity-purified IgG (3 J.1g 
IgG/J.1g sarcolemmal protein) from preimmune serum, anti-NCX, 
anti-SL or anti-82 and then assayed for exchange activity (n = 4-5). 
Sodium/calcium exchange assays were carried out using 40 JlM 
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Figure 20. Effect of Poly clonal Antibodies on Sodium/Calcium Exchange Activity 
Versus Outside Calcium ConoontratiolL Sodium-loaded sarcolemmal 
vesicles were exposed to affinity-purified IgG at 3 Jlg IgG/Jlg 
sarcolemmal protein for one hour at 37°. Sodium/calcium exchange 
activity was then assessed at varying [Ca2t-]o (5-40 JlM). Results (n = 2) 
are plotted as v/[Ca2+]0 versus v. Least squares analysis was used to 
determine values (inset) for V max (nmol/mg/sec) and KO.5 (JlM). 
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anti-S2 fractions). The cause of the larger stimulation seen with the anti-NCX and 
anti-SL fractions is uncertain. Several possibilities are: (1) stimulation by both the 
anti-NCX and anti-SL reflect nonspecific interactions; (2) stimulation may reflect 
interaction of the anti-NCX with the exchanger protein and of the anti-SL with a 
closely associated protein in the sarcolemmal membrane; or (3) the effects reflect 
interaction of the anti-NCX and a subfraction of the anti-SL with the exchanger 
protein since inability of the anti-SL to immunoprecipitate the exchanger in one 
form (detergent-solubilized) does not necessarily preclude specific interactions of a 
subset of antibodies in the IgG fraction with the exchanger in another form 
(sarcolemmal membrane). 
CHAPrERVI 
General Discussion and Future Directions 
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In the following section, several lines of evidence which support the 
conclusive identification of the cardiac Na+/Ca2f. exchanger as a protein of 140-160 
kDa are presented and discussed. 
The remaining sections will focus on N a +/Ca2+ exchange in other tissues, 
how the antibodies developed against the cardiac Na+/Ca2+ exchanger in this 
laboratory are being used elsewhere and a brief discussion of questions remaining 
to be answered and general future studies. 
IDENTIFICATION OF THE CARDIAC Na+/Ca2+ EXCHANGER 
Since Hale et al. (1984) first reported the correlation of an 82 kDa protein 
from bovine sarcolemma with Na +/Ca2+ exchange activity, a number of proteins 
ranging in molecular mass from 33 kDa to as large as 220 kDa have been proposed 
to be involved with Na+/Ca2+ exchange (Barzilai et al., 1984; Soldati et al., 1985; 
Longoni et al., 1987; Cook and Kaupp, 1988; Hale et al., 1988; Philipson et al., 1988; 
Nicoll and Applebury, 1989; Durkin et al., 1990; Ambesi et al., 1990). Identification 
has typically been based on the correlation of a specific band detected on SDS-
polyacrylamide gels with exchange activity. Although a number of minor bands 
were often detected, they were, for the most part, rejected as possible candidates. 
As this project was started, Philipson et al. (1988) reported purification of three 
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proteins (70, 120 and 160 kDa) from canine ventricle which appeared to correlate 
with exchange activity. They pointed out, however, that a number of minor bands 
were also detected. Their most convincing evidence was based on polyclonal 
antibodies generated against the enriched preparation. The antibodies 
immunoprecipitated 96% of the exchange activity from detergent-solubilized 
sarcolemma and recognized the three major proteins on immunoblots. In 
addition, a number of minor bands were detected. Curiously, prolonged exposure 
to chymotrypsin resulted in loss of signal in the three bands on immunoblots while 
exchange activity was unaffected. Whether one or more of the three bands were 
involved with Na+/Ca2+ exchange across cardiac sarcolemma was not conclusively 
determined at that time. Thus, the proteins proposed by Philipson et ale (1988) fell 
within the same category as those previously reported - inconclusive. Moreover, 
data concerning the identification of the retinal rod outer segment Na+/Ca2+-
exchanger conflicted with those obtained on the cardiac exchanger (based on 
apparent molecular weights observed on SDS-polyacrylamide gels and antibody 
cross-reactivity studies). At that time, the two exchangers were presumed to be 
identical proteins. Indeed, this was a confusing time for all in pursuit of the 
identification of the Na+/Ca2+ exchanger. 
The protein responsible for Na +/Ca2+ exchange across cardiac sarcolemma 
has now been conclusively identified as a protein of 140 ... 160 kDa. Evidence 
supporting this conclusion is based primarily upon data obtained from: 
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(1) Purification studies (Philipson et al., 1988; Ambesi et ale , 1991a; Durkin 
et al., 1991; chapter III); 
(2) polyclonal antibodies against the canine cardiac Na+/Ca2+ 
exchanger developed by two independent laboratories 
(Philipson et al., 1988; Ambesi et al., 1991a; Ambesi et ale , 
1991b; Ambesi et al., 1991c); 
(3) molecular cloning of the canIne cardiac sarcolemmal 
Na +/Ca2t- exchanger (Nicoll et al., 1990). 
Philipson et ale (1988) reported purification of the Na+/Ca2t- exchanger from 
canine ventricle and correlated proteins of 70 and 120 kDa (reducing conditions) 
with a relatively high specific activity (654 nmol/mg/sec). Under nonreducing 
conditions, a single protein was detected with a molecular mass of 160 kDa. 
Subsequently, Ambesi et ale (1990) and Durkin et ale (1990) reported purification of 
the Na+/Ca2+ exchanger from canine and bovine cardiac sarcolemma, 
respectively, and correlated proteins of 70 and 120 kDa (Ambesi et al., 1990) and 150 
kDa (Durkin et al., 1990) with specific activities of 2791 nmollmg/sec (Ambesi et ale , 
1990) and -1 J.1mollmg/sec (Durkin et al., 1990). Later, proteins of 75, 120 and 140 
kDa (specific activity = 3766 nmollmg/sec; Ambesi et al., 1991a) and 120 and 160 
kDa (specific activity = 1 J.1mollmg/sec; Durkin et al., 1991) were reported to be 
associated with exchange activity. Thus, data obtained by three independent 
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laboratories agreed quite closely with respect to the proteins observed in their 
purified preparations. 
Polyclonal antibodies generated by Philipson et ale (1988) against the 
partially purified preparation immunoprecipitated 96% of the exchange activity 
form detergent-solubilized sarcolemma and recognized proteins of 70, 120 and 160 
kDa on immunoblots of sarcolemmal proteins. These antibodies were kindly 
provided to this laboratory by K. D. Philipson and were found to immunoreact with 
proteins of 75, 120 and 140 kDa (reducing conditions) in our purified Na+/Ca2+ 
exchange preparation as well as in our sarcolemma preparations (Ambesi et al. , 
1991c). Moreover, these antibodies also recognized proteins of 70, 120 and 160 kDa 
purified from bovine heart (identified as the cardiac Na+/Ca2+ exchanger; Durkin 
et ale , 1991). 
The polyclonal antibodies generated against the purified Na+/Ca2+ 
exchange preparation developed in this laboratory (Ambesi et al., 1991a; chapter 
III and IV) immunoprecipitated 97% of the Na+/Ca2+ exchange activity from 
detergent-solubilized sarcolemma and immunoreacted with proteins of 75, 120 and 
140 kDa (reducing conditions) in our purified Na+/Ca2t- exchange preparation and 
sarcolemma preparations. Furthermore, the antibodies directed against each of 
the three proteins (75, 120 and 140 kDa) were antigen-purified and shown to 
immunoprecipitate 92, 91 and 83%, respectively, of the exchange activity from 
detergent-solubilized sarcolemma (chapter IV). The antigen-purified antibodies 
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also cross-reacted with each of the other two proteins on immunoblots of 
sarcolemmal protein (chapter IV). These data suggest that the three proteins 
observed in this laboratory (75, 120 and 140 kDa) are all associated with Na+/Ca2f. 
exchange across cardiac sarcolemma and appear to be identical to those observed 
by Philipson and associates (Philipson et al., 1988; Vemuri et al., 1990; Nicoll et al., 
1990) and by Reeves and associates (Durkin et al., 1990; Durkin et al., 1991). 
Evidence obtained from proteolytic treatment of the purified Na+/Ca2f. 
exchanger (Philipson et al., 1988), amino acid sequencing of the NH2-terminal 
regions of the 120 and 160 kDa proteins (Durkin et al., 1991) and immunoblots of 
isolated canine ventricular myocytes (chapter IV) also support the hypothesis that 
the 75 and 120 kDa proteins are proteolytic fragments of the 140 kDa protein. 
The polyclonal antibodies generated against the purified canine cardiac 
exchanger preparation (Philipson et al. , 1988) were subsequently used to isolate a 
cDNA clone leading to expression of functional Na+/Ca2+ exchange activity in 
Xenopus oocytes (Nicoll et al., 1990). The cDNA codes for a protein of 907 amino 
acids (-108 kDa) possessing six potential glycosylation sites and a single potential 
phosphorylation site. Antibodies developed against a synthetic peptide from the 
deduced amino acid sequence immunoreact with sarcolemmal proteins of 70, 120 
and 160 kDa on immunoblots which supports the earlier results of Philipson and 
associates (Philipson et al. , 1988; Vemuri et al. , 1990) as well as those reported in 
chapters III and IV. The cardiac exchanger possesses a 32 amino acid signal 
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sequence as determined by NH2-terminal amino acid sequencing of the 120 and 160 
kDa proteins (amino terminals for the 120 and 160 kDa proteins from bovine heart 
are identical to one another and to those from canine heart) extracted from SDS-
polyacrylamide gels (Durkin et al., 1991). 
There is also a consensus sequence for a calmodulin binding site. This was 
further tested using synthetic peptides. A peptide based on the deduced amino 
acid sequence corresponding to the potential calmodulin binding site was 
synthesized and tested for the ability to bind calmodulin (Li et al., 1991). The 
peptide did, indeed, bind calmodulin with high affinity and was also shown to 
inhibit exchange activity in sarcolemmal vesicles as well as in intact ventricular 
cells and giant excised membrane patches (the peptide has been termed 'XIP' for 
exchanger inhibitory peptide). 
Several explanations could account for the discrepancy between the 
molecular mass observed on SDS-PAGE (140-160 kDa) and that from the deduced 
amino acid sequence (108 kDa minus a 32 amino acid signal sequence; Durkin et 
al., 1991). Firstly, the apparent molecular weight may reflect anomalous behavior 
noted for many proteins upon SDS-PAGE in which proteins migrate differently 
from their actual molecular weight (Andrews, 1986). This may be due to 
incomplete SDS binding (due to protein glycosylation or incomplete protein 
unfolding; Andrews, 1986). Secondly, the molecular weight deduced from the 
cDNA does not account for glycosylation. Given that there are six potential 
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glycosylation sites (Nicoll et al. , 1990), the exchanger may be heavily glycosylated. 
Furthermore, the difference may reflect a combination of glycosylation and 
anomalous behavior upon SDS-PAGE. 
Radiation inactivation studies (Hale et al., 1988; Smith and Lindenmayer, 
in preparation) and results from size exclusion chromatography (Hale et al., 1988; 
chapter III) suggest that the molecular weight of the functional complex 
responsible for Na+/Ca2f. exchange is much larger than that observed on SDS-
PAGE or obtained from the deduced amino acid sequence. Thus, the active 
exchanger may be multimeric. Protein regulators (inhibitors and/or activators of 
exchange activity) that might contribute to a multimeric complex, however, have 
not as yet been observed .. 
Na+/Ca2+ EXCHANGE IN OTIlER TISSUES 
In addition to cardiac tissue, Na+/Ca2+ exchange activity has been observed 
in neuronal tissue (Schellenberg and Swanson, 1981; Gill et al., 1981; Coutinho et 
al., 1983; Barzilai et al., 1984; Fontana and Blaustein, 1991), renal proximal 
tubules (Lorenzen et al., 1985; Dominguez et al., 1991), epithelial cells (Taylor, 
1989), skeletal muscle (Hidalgo, 1991), smooth muscle (Blaustein, 1989), 
neutrophils (Dale and Simchowitz, 1991), red blood cells (Milanick and Frame, 
1991), retinal rod cells (Lagnado and McNaughton, 1989), platelets (Haynes et al. , 
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1991) and endothelial cells (Hansen and O'Donnell, 1991). 
Solubilization and reconstitution of functional Na+/Ca2+ exchange activity 
from plasma membranes isolated from rat brain synaptic plasma membranes 
(Barzilai et al., 1984), aortic smooth muscle (Matlib and Reeves, 1987) and retinal 
rod outer segments (Cook and Kaupp, 1988; Nicoll and Applebury, 1989) have been 
reported. However, activities are consistently lower than those observed from 
cardiac tissue. Matlib and Reeves (1987) solubilized plasma membrane vesicles 
from rat mesenteric arteries with cholatelasolectin and reconstituted by detergent 
dilution. Activities in reconstituted vesicles were enriched 4-fold over isolated 
native membranes (native membranes = 0.5 nmols/mg/sec; reconstituted vesicles 
= 2.0 nmols/mg/sec). 
Barzilai et ale (1984) solubilized brain synaptic plasma membrane vesicles 
with cholate in the presence of purified brain phospholipids and reconstituted 
Na+/Ca2f. exchange activity by dialysis. After sucrose gradient centrifugation of 
reconstituted vesicles, exchange activity was enriched -70-fold (native synaptic 
membranes = 25 nmols/mg/5 min; reconstituted vesicles = 34 nmols/mg/5 min; 
sucrose gradient fraction = 2396 nmols/mg/5 min; note that these activities are 
based on 5 minute assays as opposed to the usual one second assay). Activity 
appeared to correlate with a 70 kDa band on SDS-PAGE. Antibodies directed 
against the 70 kDa band also recognized a 33 kDa band and immunoprecipitated 
53-820/0 of the activity (Barzilai et al., 1987). These results, to some extent, appear to 
11 6 
be in agreement with those of Philipson et ale (1988) and with those reported in 
chapter III in which Na +/Ca2+ exchange activity correlates with a protein of 70-75 
kDa. We attribute this protein, however, to breakdown of a larger parent 
exchanger protein of 140 kDa (chapter IV). Furthermore, Yip et ale (1991) used 
polyclonal antibodies developed against the canine cardiac sarcolemmal Na +/Ca2f. 
exchanger (Philipson et al., 1988) to show cross-reactivity with protein bands of 70, 
120 and 160 kDa on western blots of rat brain synaptic plasma membrane proteins 
solubilized with decylmaltoside. In collaboration with Blaustein and associates, 
similar results were obtained with polyclonal antibodies developed in this 
laboratory (unpublished data). These data suggest that the cardiac and brain 
Na +/Ca2f. exchangers are identical, but does not preclude the possibility that other 
proteins manifesting Na+/Ca2+ exchange could exist in the central nervous system 
(see below). 
Cook and Kaupp (1988) combined DEAE-Fractogel-TSK chromatography 
and AF Red Fractogel-TSK chromatography with either Sepharose CL-4B gel 
filtration or concanavalin A affinity chromatography to purify exchange activity 
from retinal rod outer segments. The AF Red Fractogel-TSK column was used to 
bind the cGMP-gated cation channel, a major contaminant at this stage, while 
Na+/Ca2f. exchange activity was not bound. Final purification resulted in lOB-fold 
enrichment with 21% recovery of Na+/Ca2+ exchange activity which appeared to be 
associated with a 220 kDa band on reducing SDS-PAGE. They reported a specific 
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activity of 8166 nmols/mg/min. Assuming initial velocity conditions, this equates 
to 136 nmoVmglsec for the ROS exchanger versus 3766 for the exchanger purified 
from cardiac tissue (see chapter III). These results were later confirmed by Nicoll 
and Applebury (1989) in which Na+/Ca2+ exchange activity was purified from 
bovine retinal rod outer segments and was found to correlate with a single band of 
-215 kDa upon SDS-PAGE. Activity reported for their most enriched preparation 
was also quite low relative to that obtained from cardiac tissue (Philipson et al., 
1988; Ambesi et al., 1990; Ambesi et al., 1991a; see chapter III; Durkin et ale , 1991). 
The lower activities observed in purified preparations of the ROS Na +/Ca2t-
exchanger relative to those from cardiac tissue supports the idea that the Na+/Ca2+ 
exchanger protein may vary from tissue to tissue. Further evidence comes from 
the recent cloning of the cDNA for the bovine retinal rod outer segment Na+/Ca2+ 
exchanger (Cook et ale ,1991). While "topological similarities" between the ROS 
Na+/Ca2+ exchanger and the cardiac Na+/Ca2t- exchanger were reported, the two 
proteins possess no amino acid homology (Cook et al., 1991). 
Since activities enriched from noncardiac membrane preparations are low 
in comparison to those from cardiac tissue, Na+/Ca2+ exchange may reflect a 
variation in the expression of the exchanger protein, and/or modulators of 
exchange activity, from tissue to tissue. Alternatively, Na+/Ca2+ exchange may 
reflect a family of functionally similar proteins coded by completely different genes 
(as in the case of the cardiac and ROS Na+/Ca2+ exchangers) and/or by different 
118 
genes which exhibit some degree of homology. Indeed, we have attempted to detect 
Na+/Ca2f.. exchange protein on immunoblots of canine kidney microsomal 
preparations (chapter IV), cultured bovine pulmonary artery endothelial cells, 
and cultured rat thoracic aorta vascular smooth muscle cells. Although there 
have been reports ofNa+/Ca2+ exchange activity being measured in these cell types 
(kidney: Lorenzen et al., 1985; Smith et al., 1991; cultured bovine endothelial cells: 
Hansen and O'Donnell, 1991; rat aorta vascular smooth muscle cells: Ashida and 
Blaustein, 1987), only trace amounts, at most, of the Na +/Ca2+ exchange protein 
were detected. The data indicate that (1) too little exchanger protein was applied to 
the gel (suggesting low exchanger density relative to cardiac tissue) or (2) the 
Na +/Ca2+ exchanger in these tissues is sufficiently different from the cardiac 
exchanger such that antibodies were unable to recognize the exchanger from 
these tissues. 
Conversely, evidence based on immunoblots of rat synaptic plasma 
membranes (Yip et al., 1991) and immunofluorescence microscopy (see below) 
clearly indicates that the protein responsible for N a +/Ca2+ exchange in heart is 
present in neuronal tissue. 
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LOCALIZATION OF Na+/Ca2+ EXCHANGE IN NEURONAL TISSUE BY 
IMMUNOFLUORESCENCE MICROSCOPY 
The polyclonal antibodies developed by the author against the canine 
cardiac Na +/Ca2f. exchanger are currently being used by Blaustein and associates 
to localize the Na+/Ca2+ exchanger in neuronal cells by immunofluorescence 
microscopy (Luther et al., 1991). These antibodies have been shown to recognize 
proteins in rat synaptic plasma membranes on immunoblots comparable to those 
observed in canine, bovine, porcine and rat cardiac membrane preparations. 
Through the use of immunofluorescence microscopy, the antiserum (but not 
preimmune serum) was found to react intensely and selectively at the 
neuromuscular junctions (identified by tetramethylrhodamine-a -bungarotoxin 
binding) in frozen cross sections of adult rat diaphragm muscle. Furthermore, 
the antiserum reacted with neuronal axons in fixed and detergent-permeabilized 
Xenopus nerve and muscle co-cultures. The most intense labeling was found on 
the presynaptic terminals of the neuromuscular junction where the nerve had 
been separated from the muscle. 
These studies support the hypothesis that the cardiac and neuronal 
Na+/Ca2f. exchangers are identical (unlike the Na+/Ca2+ exchanger from the outer 
segments of retinal rod cells) and that Na+/Ca2+ exchange in nerve terminals may 
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be functionally important in Ca2+ homeostasis. Evidence supporting Ca2t- effiux as 
the primary role of Na +/Ca2+ exchange in cardiac muscle leads one to suspect that 
Na+/Ca2t- exchange in nerve terminals may playa similar role. Subsequent to 
Ca2+ influx and neurotransmitter release, Ca2t- effiux via the Na +/Ca2+- exchanger 
may provide the signal necessary to terminate transmission. 
FUrURE STUDIES 
Now that the cDNA for the cardiac Na+/Ca2t- exchanger has been cloned 
(Nicoll et al., 1990) and purification schemes have been developed (Philipson et al., 
1988; Ambesi et al., 1991c; Durkin et ale , 1991), a number of questions can be 
addressed. Among the first is whether the active exchanger is multimeric (see 
chapter III). Bifunctional cross-linking reagents could be used to determine if the 
active exchanger consists of a dimer or higher order of the 140 kDa protein or 
possibly involves as yet unidentified subunits. Undoubtedly, site-directed 
mutagenesis will playa fundamental role in addressing many structure/function 
questions. For example, through site-directed mutagenesis, sites involved in the 
ion translocation pathway, as well as the site involved in the regulation of 
Na+/Ca2t- exchange by intracellular Ca2+, may be identified. In addition, it may be 
possible to answer questions concerning the mechanism of exchange. For 
example, is Na+/Ca2+ exchange carried out by a consecutive (Na+ and Ca2t-
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transported sequentially) or by a simultaneous mechanism (Na+ and Ca2+-
transported at the same time)? 
Sites of phosphorylation and glycosylation can be determined, thereby 
facilitating studies addressing the regulation of exchange activity. 
With DNA probes constructed from the cloned eDNA, questions such as 
tissue specificity and levels of expression in various tissues can be addressed, 
ultimately determining whether or not the Na +/Ca2+ exchanger consists of a 
number of functionally similar proteins encoded by distinctly different genes or 
genes that posses some homology. 
When sufficient amounts of the exchanger are purified, either from whole 
tissue or from cells over-expressing the exchanger, structural information may be 
determined with nuclear magnetic resonance spectroscopy. With the advances 
being made in crystallography, it may ultimately be possible to generate high 
quality crystals and obtain high resolution X-ray crystal structures of the Na+/Ca2+ 
exchanger. Determination of the 3-dimensional structure could lead to the design 
of more selective, high affinity ligands which may be used to assess the 
physiological significance of Na+/Ca2+ exchange in the cardiac cell and possibly in 
other cell types through pharmacological approaches. 
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